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ABSTRACT
Although the rendering process serves as invaluable means for the disposal of
inedible animal by-products, the finished products often harbor pathogenic and
opportunistic microorganisms such as Salmonella and enterococci, respectively. The
temperatures used during the rendering process far exceed the heat tolerance threshold of
most bacterial species, so cross-contamination from the environment and/or from the
incoming raw material is the proposed source of the contamination. Research has
demonstrated that the raw material coming into the rendering facility is highly
contaminated with pathogenic bacteria including Salmonella. While not in a rendering
facility, studies have also demonstrated that bacteria such as Salmonella can persist on
food processing equipment and be transferred into the product upon contact. The
objectives of this study were to: 1) isolate and characterize Salmonella and enterococci
from finished animal by-products, 2) produce and optimize a bacteriophage cocktail
against Salmonella, 3) apply the bacteriophages to reduce Salmonella levels on
environmental surfaces found in a rendering facility and in raw offal, and 4) use the
bacteriophage as a feed additive to reduce or prevent Salmonella infection in mice.
To determine the prevalence of Salmonella and enterococci, two hundred finished
meals provided by various rendering facilities across the U.S. were analyzed. While the
animal meals were shown to not be a suitable environment for bacterial growth (moisture
content 1.9 to 11.5%), these products did contain enterococci and Salmonella.
Enterococci were detected in 83% of the samples and accounted for up to 54% of the
total bacterial count, which ranged from 1.7 to 6.8 log CFU/g. Characterization of the
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enterococci isolates revealed that only 3 isolates were resistant to vancomycin (32
µg/ml). PCR analysis revealed that none of these 3 VRE isolates were E. faecalis or E.
faecium. In addition, no VRE isolates were of the VanA or VanB-type, which confer the
highest levels of resistance to vancomycin. Salmonella (n = ? ) was isolated from 8.7% of
the finished meal samples. There were 13 Salmonella serotypes identified among the
isolates with 16 pulse field gel electrophoresis (PFGE) patterns. Thermal tolerance
studies revealed that these Salmonella isolates had D-values of 9.27-9.99, 2.07-2.28, and
0.35-0.40 min at 55°C, 60°C, and 65°C, respectively.
As a means to prevent or reduce Salmonella contamination, bacteriophages were
isolated from raw chicken offal that would be used for rendering. Bacteriophages were
isolated by using the Salmonella spp. isolated previously from the finished meals as the
host bacteria. For further study, five of the isolated bacteriophages (n = ? ) were selected
to produce a cocktail for bacteriophage treatment studies. The selection was based on
which bacteriophage had the highest lytic activity against 5 pre-determined Salmonella
serotypes, i.e., Enteritidis, Idikan, Johannesburg, Mbandaka, and Typhimurium. Prior to
bacteriophage treatment studies, the optimal bacteriophage cocktail concentration was
determined by multiplicity of infection (MOI) optimization. Initial results indicated that
an actively growing culture is needed for lytic activity of bacteriophages. When using an
actively growing Salmonella cocktail, the effectiveness of the bacteriophage cocktail was
shown to increase by raising the MOI from 1 to 10, whereas MOI of 50 didn’t enhance
the lytic activity further. MOI optimization also revealed that resistance strains of the
Salmonella spp. are selected for quickly (12 h), but that the lytic activity of the
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bacteriophage treatment is easily extended through the addition of a different
bacteriophage cocktail at the 12 h mark.
The optimized bacteriophage cocktail was able to successfully reduce Salmonella
levels on all tested environmental surfaces (HDPE plastic, cement, rubber, stainless
steel). Treatment of Salmonella cells attached to the environmental surfaces resulted in a
2 log CFU/cm2 reduction at 40° and 30°C, and ca. 1 log CFU/cm2 reduction at 20°C on
all surface materials. The presence of an organic layer on the surface had identical levels
of reduction, indicating the organic material does not interfere with the bacteriophage’s
lytic activity. Treatment of the single species biofilm resulted in ca. 1-2, 2-3, and 1 log
CFU/cm2 reduction in S. Enteritidis H4717 populations on all surface materials at 20, 30,
and 40°C, respectively, as compared with ca. 0.5, 1.5-2, and 0.5 log CFU/cm2 reduction
in S. Enteritidis populations of the double species biofilm under the same experimental
condition.
In addition to the surface materials, the bacteriophage cocktail was shown to
reduce Salmonella levels in raw chicken offal. When treating irradiated raw offal that was
artificially contaminated with the Salmonella cocktail (105 CFU/g), the bacteriophage
cocktail reduced Salmonella levels by ca. 2.0, 2.7, and 2.5 log CFU/g at 20°, 30°, and
40°C, respectively. The bacteriophage was also capable of reducing Salmonella levels to
the same degree, i.e., ca. 2.0, 2.2, and 2.2 log CFU/g at 20°, 30°, and 40°C, respectively,
in the non-sterile raw chicken offal at the presence of background microorganisms.
The bacteriophage cocktail was also evaluated as a feed additive. The
bacteriophage cocktail was lyophilized and added into the animal meals (blood, feather,
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and poultry), which were artificially contaminated with a five-strain Salmonella cocktail
at initial level of ca. 105 CFU/g. A series of dehydration studies revealed that the addition
of dehydrated bacteriophages to finished meals does not reduce the level of Salmonella
present upon rehydration; however, there was an observable difference between those
samples containing the bacteriophages and those that did not after 12 h of rehydration,
with those containing the bacteriophages having lower levels of Salmonella (ca. 2 log
CFU/g difference ??). Our results also revealed that the bacteriophage cocktail’s stability
was reduced quickly when applied in a dehydrated form. The concentration of the
dehydrated bacteriophage decreased by 1.5 log PFU/g within the rendered meal over a 4
week period at 30°C. However, the stability of the bacteriophage was maintained well
when the bacteriophage was added to the animal feed in liquid form and stored under
refrigeration conditions (4°C). Under these conditions, the bacteriophage cocktail’s
concentration decreased by 0.23 log PFU/g over a 4 week period.
The liquid bacteriophage was then supplemented into animal feed and given to
mice during an animal trial. The mice that had been given a diet containing the
bacteriophage for a period of a week prior to Salmonella inoculation were not infected as
evidenced through fecal sampling. These mice shed no Salmonella in their feces over a 4
week period. Mice that had not been given the diet supplemented with the bacteriophage
shed Salmonella in their feces for a period of 2.5 weeks. Histological analysis of the liver
and intestine also indicated no observable signs of inflammation in those mice given the
bacteriophages. In mice not receiving the bacteriophage treatment, venous dilation,
cholangiohepatitis, and monocytes in the portal areas were observed in the liver.
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Our results indicate that the Salmonella contamination of finished rendered meals
is likely the source of cross-contamination between the environment or the incoming raw
material and the finished products. The risk for cross-contamination may be reduced
through the use of bacteriophage treatment which was found to reduce ca. 99 to 99.9% of
Salmonella levels on both the environmental surfaces and raw material. The
bacteriophage cocktail was also found to have the potential to be used as a feed additive
to reduce pathogen levels within an animal host when added to the feed in liquid form
just prior to consumption.
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CHAPTER ONE
LITERATURE REVIEW
The Rendering Industry: An Overview
In the U.S. alone, approximately 100 million hogs, 35 million cattle, and eight billion
chickens are slaughtered for consumption annually (Meeker and Hamilton, 2006). This leads to a
large amount of by-products which include, skin, hair, hides, hoofs, horns, feet, heads, bones, toe
nails, blood organs, glands, intestines, muscle and fat tissue, feathers, shells, and in some
instances an entire carcass. On average, approximately 50% of an animal used for food
production (meat, milk, and eggs) is not consumed by humans. To break it down further,
“approximately 49% of the live weight of cattle, 44% of the live weight of pigs, 37% of the live
weight of broilers, and 57% of the live weight of most fish species are materials not consumed
by humans” (Ockerman and Hansen, 1988; Meeker and Hamilton, 2006). The increasing use of
pre-packaged and ready-to-eat (RTE) meat products has further increased the amount of material
intake for rendering over the past few years. Currently, the U.S. has an approximate raw material
intake of 54 billion pounds per year as compared with ca. 5 billion pounds of raw material in
Canada. The composition of these raw materials is reported to be 60% water, 20% protein and
mineral, and 20% fat (Meeker and Hamilton, 2006). These materials spoil quickly and are highly
contaminated with microorganism including those that are pathogenic to humans; therefore,
rendering is a fast and efficient way of disposing of these materials and eliminating the
microorganisms from the finished product (Meeker and Hamilton, 2006; Aird and Spragg, 2005).
The rendering process breaks down these animal by-products (those not suitable for
human consumption) by physical and chemical manipulation. In general there are four categories
of rendering systems: wet rendering, batch rendering, dry continuous, and continuous lowtemperature rendering (Ockerman and Hansen, 1988). All rendering methods use heat to
1

thoroughly cook the material followed by moisture removal and fat extraction. The temperature
used and the length of application are crucial to the quality of the finished product. Although
both factors vary depending on the raw material being processed, the rendering process involves
a set of general steps regardless of the raw material. Initially all raw material is transported to an
area in the facility where it is ground and fed onto a conveyer that transports it into the cooker.
The cooking process typically lasts for 40-90 minutes at 115° to 145°C (Meeker and Hamilton,
2006). Once the material has been thoroughly cooked, the melted fat is separated and the
majority of the moisture is removed. This separation of fat is performed in a closed vessel using
a screw press. The remaining material, “cracklings”, is ground further and has additional
moisture removed (Ockerman and Hansen, 1988). When the “cracklings” have been ground to
sufficient size particles, both the processed protein meal and fat are either transferred to a storage
facility or shipped out to a consumer (Meeker and Hamilton, 2006).
There are approximately 300 rendering facilities in North America. The rendering facility
processes the inedible animal by-products into many valuable products, the largest of which is
meals used as supplements in animal feed. The type of meal is dependent on the raw material it
is produced from. There is a wide range of meal types which includes meat and bone meal, meat
meal, poultry meal, hydrolyzed feather meal, blood meal, and fish meal (Meeker and Hamilton,
2006). A breakdown on the application of two meal types (meat and bone meal and blood meal)
is presented in Table 1.1.
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Table 1.1 Domestic use of animal proteins by various animal species1
Meat and Bone Meal
Blood Meal
Species fed
Million pounds
Percentage
Million pounds
Percentage
Ruminants
567.4
10
158.55
70
Swine
737.6
13
45.3
20
Poultry
2439.6
43
22.65
10
Pet food
1304.9
23
Other
624.1
11
Total

5673.5

100

226.5

100

1 (Sparks, 2001)

Rendering Processes
Modern rendering facilities have made vast improvements in the technology and
processes used over the past several years. Current facilities are constructed so as to separate the
incoming raw material from other areas of the facility such as the processing and storage areas.
The rendering process is controlled by a computer system that regulates the temperature, time,
and in some cases pressure during processing. The technology ensures that the raw material
receives sufficient treatment to achieve thermal kill time requirements for the pathogenic
microorganisms. In the mean time, it prevents overheating of the material which will lead to a
decrease in the nutritional value and digestibility of the finished product (Meeker and Hamilton,
2006).
Essentially there are two major types of rendered processing, wet and dry rendering. In a
wet rendering system, there is high moisture content in the finished product, which may or may
not be dried. This form of rendering is primarily used for the production of edible fats and oils.
Early wet rendering systems were of simple design and involved cooking the fat in an open kettle
heated over a wood fire or hot coal. The fat would rise to the top and was skimmed off
(Anderson, 2006). Current methods for wet rendering include loading the raw material into a
3

vertical digestor where steam is injected into the material through the perforated plates in the
digestor. This method of rendering is being gradually phased out due to several disadvantages
including: long cooking times, labor intensive, and up to 25% of the meal can be lost during
processing (Ockerman and Hansen, 1988).
Dry rendering systems are the most common form of rendering used today. Dry rendering
is accomplished through one of two system designs, batch rendering or continuous rendering.
The use of batch cooking rendering systems began to be universally used during the later part of
the twentieth century. A batch system is designed to be “loaded, processed to a percentage dry,
and then discharged for fat separation” (Anderson, 2006). In a batch system, a batch cooker can
be used to cook, dry, hydrolyze, or process raw material. Originally, large pieces of animal meat
or offal would be pressure cooked in a batch system prior to drying, which would make the
bones softer and easier to handle. Modern particle reduction technology has eliminated the need
for pressure cooking, but it is still used in Europe as means to further reduce bovine spongiform
encephalopathy (BSE) causing prions. Pressure cooking is being used in the processing of hair
and feathers to make the associated proteins more digestible. For example, the pressure is needed
to break down the bonds in the keratin proteins found in feathers. While chemicals could break
the bonds post-processing by 100%, the chemicals also destroy the amino acids produced from
protein degradation (Anderson, 2006). While batch systems do offer the major advantage of
being able to cook, pressurize, and sterilize within the same vesicle, it has more disadvantages
than continuous rendering systems. These disadvantages include: the meat based by-products
must be cut and washed which adds ca. 35% to the moisture content, problems processing
gelatinous material, the material is not contained in enclosed vesicles making it susceptible to
contamination, labor intensive, and inefficient drying (Ockerman and Hansen, 1988).
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Continuous rendering has undergone many structural changes over time. One of the
earliest continuous systems developed was the Anco Strata-Flow system. This system was
composed of batch cookers that had been modified and linked together to form a continuous
processing system with each batch cooker responsible for a specific aspect of the rendering
process. Since then, several adaptations have been made to the design including the DUKE,
Carvo-Greenfield, Atlas, and the Stord-Bartz systems (Anderson, 2006). Regardless of the
design, the flow of raw material through a continuous rendering system is the same. Initially, raw
material is transferred into a grinder where the material is ground into small uniform particles.
The particles are then transferred into a continuous cooker where they are heated to 115°-145°C
with steam. Once the material has been adequately cooked, the liquid fat and solid material are
separated using a drainer conveyor. The solid material is fed into a screw press to reduce the fat
content to ca. 10-12%. The solid material is then combined to form the finished meal.(Ockerman
and Hansen, 1988; Anderson, 2006). The continuous rendering system is outlined in Figure 1.1
(Anderson, 2006).
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Figure 1.1. Continuous Rendering System Outline1
1 Available at: http://nationalrenderers.org/assets/flow_charts.pdf
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Finished Rendered Products
Annually, the U.S. rendering industry produces ca. 11.2 billion pounds of protein and
10.9 billion pounds of fats. About 85% of these products are then used in the production of
animal feed ingredients (Meeker and Hamilton, 2006). The composition of these feed ingredients
is defined by the National Research Council (NRC) or the Association of American Feed Control
Officials (AAFCO), which puts out and updated manual annually with feed ingredient guidelines
(Aird and Spragg., 2005). Table 1.2 outlines the nutrient composition of commonly used
rendered products. As of 2006, the AAFCO manual referenced ca. 125 individual animal byproducts produced in the U.S. (Meeker and Hamilton, 2006). Some major meal types are
discussed in detail in the following paragraphs.
According to AAFCO, meat and bone meal (MBM) is made from mammalian tissues
including the bone but excluding blood, hide, horn, hooves, stomach or rumen contents, or hair.
MBM must also have a phosphorus content of at least 4% and a calcium level less than 2.2 times
the phosphorus level. If the phosphorus content is less than 4%, the meal is defined as meat meal
(Meeker and Hamilton, 2006). In addition, the meal cannot contain more than 12% and 9%
indigestible pepsin residue and crude protein, respectively; however, in other countries such as
Australia the amount of indigestible pepsin is slightly higher at ca. 15% (Meeker and Hamilton,
2006; Aird and Spragg., 2005). MBM of poultry origin is used for all species of livestock;
however, ruminants cannot be fed meals that have been made from ruminant animals as outlined
by the feed law passed by the FDA in 1997 (title 21, Code of Federal Regulations, Part
589.2000) to prevent the transference of BSE (Meeker and Hamilton, 2006).
Poultry bone meal (PBM) by definition is composed from the cleaned carcass of poultry
including the neck, feet, undeveloped eggs, and intestines. Some feathers are unavoidably
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incorporated into the raw material, but in general the product is free of feathers. Like MBM, the
calcium level in PBM must not exceed the phosphorus level by more than 2.2 times the amount
(Meeker and Hamilton, 20006). The NRC has the calcium content listed at ca. 10.3% and the
phosphorus content at 5.1% (Aird and Spragg., 2005). PBM is usually of high quality with
essential amino acids, vitamins, minerals, and fatty acids, so it has been commonly used to
produce pet grade feed (Meeker and Hamilton, 2006; Aird and Spragg., 2005).
The feathers not used to produce poultry meal can be used to produce feather meal
(FeM). The largest market for unused feathers is in meal production (Ockerman and Hansen,
1988). A minimum of 75% of the meal’s crude protein must be digestible by pepsin. The
undecomposed feathers are cooked under pressure to break the keratin protein bonds, which
results in a feather meal that is free-flowing and easily digestible by all species of livestock
(Meeker and Hamilton, 2006). Typically the finished feather meal far exceeds the digestibility
guidelines set by AAFCO, but digestibility in ruminant animals has been shown to increase
through the addition of urea to the meal (Ockerman and Hansen, 1988). A unique aspect of this
meal type is that it is an excellent source for sulfur containing amino acids, particularly cystine
(Meeker and Hamilton, 2006); however, it is deficient in lysine, methionine, histidine, and
tryptophan (Ockerman and Hansen, 1988).
In addition to inedible animal parts and feathers, clean (free of hair, urine, and stomach
contents) blood from slaughtered animals can also be used to produce finished, rendered byproducts. Initially, blood is treated by removing a large amount of the moisture by mechanical
dewatering or turning the blood into a semi-solid state by coagulating it with steam. In this
instance, the semi-solid masses are flash dried to rapidly remove the remaining moisture content.
According to AAFCO guidelines, the minimum biological activity of lysine within the finished
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meal must be at least 80% (Meeker and Hamilton, 2006; Ockerman and Hansen 1988). During
the 1960s and 1970s, blood meal production was limited due to the vat-drying procedures which
significantly lowered the bioactivity of lysine. With newer methods of drying (ring or flashdrying), blood meal not only has the highest amount of lysine but is the richest source of protein
for animal feed as well (Meeker and Hamilton, 2006). The ring drying system has been shown to
increase the amount of biologically active lysine by ca. 34% and the amount of protein by 7.5%
in blood meal (Ockerman and Hansen, 1988).
Table 1.2 Nutrient composition of animal proteins1
Item
Crude Protein %
Fat %
Calcium %
Phosphorus %

Meat and Bone
Meal
50.40
10.00
10.30
5.10

Blood
Meal2
88.90
1.00
0.40
0.30

Feather
Meal
81.00
7.00
0.30
0.50

Poultry
Meal
60.00
13.00
3.00
1.70

TMEN3 kcal/kg
Methionine %
Cystine %
Lysine %
Threonin %
Isoleucine %
Valine %
Tryptophan %
Arginine %
Histidine %
Leucine %
Phenylalanine %
Tyrosine %
Glycine %
Serine %

2666
0.70
0.70
2.60
1.70
1.50
2.40
0.30
3.30
1.00
3.30
1.80
1.20
6.70
2.20

3625
0.60
0.50
7.10
3.20
1.00
7.30
1.30
3.60
3.50
10.50
5.70
2.10
4.60
4.30

3276
0.60
4.30
2.30
3.80
3.90
5.90
0.60
5.60
0.90
6.90
3.90
2.50
6.10
8.50

3120
1.00
1.00
3.10
2.20
2.20
2.90
0.40
3.90
1.10
4.00
2.30
1.70
6.20
2.70

1 (National Research Council 2004)
2 Ring or flash dried
3 TME = true metabolizable energy nitrogen corrected (Dale, 1997)
N
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Microbiological Safety of the Rendering Process
In addition to producing a profitable end product, the rendering industry also plays a
major role in removing pathogenic microorganisms from the food chain. The effective treatment
of pathogenic microorganisms in the incoming animal by-products has been documented by
some research (Troutt et al., 2001).
The incoming raw material serves as a reservoir for many pathogenic bacteria. Cattle
have been reported with a 23% contamination rate with E. coli O157:H7 (Smith et al., 2001), a
50% contamination rate with Salmonella (Troutt et al., 2001), and a 39% contamination rate with
Cryptosporidium parvum (Huetink, 2001). Poultry has been reported with up to a 100%
contamination rate by Salmonella (Council of Agricultural Science and Technology, 1994).
Swine have been reported to be contaminated with Salmonella (46%) and Yersina enterocolitica
(49%) (Swanenburg et al., 2001; Council of Agricultural Science and Technology, 1994).
One of the major microbial contaminants in finished feed is Salmonella. As mentioned
previously, the rendering process should effectively eliminate Salmonella, but one of the major
issues facing the rendering industry is cross-contamination from the incoming raw material
(Ockerman and Hansen, 1988). Once the meal is contaminated with Salmonella, it is
incorporated into the finished feed given to livestock. This allows Salmonella to continuosly
enter the food chain. Several studies have been able to link cases of Salmonella infection in
humans to contaminated animal feed. Boyer et al. (1958) established a link between serotypes of
Salmonella recovered from humans and animals to feed ingredients and animal feed. A year
later, Watkins et al. (1959) was able to recover 28 different serotypes of Salmonella from 18.5%
of animal by-products sampled. Pomeroy et al. (1961) expanded on Watkins work by collecting
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samples from 22 states across the United States. In total, Salmonella was identified in 170 of the
980 samples tested with 43 serotypes identified.
The problem with Salmonella was further illustrated by a Salmonella agona outbreak.
From 1969 to 1970, S. agona was identified as a public health concern in the United States,
United Kingdom, Netherlands, and Israel. In each country, initial detection of S. agona in fish
meal was followed by the detection of the pathogen in domestic animals and humans (Clark et al.
1973). By 1972, S. agona was the 8th most commonly isolated serotype in the United States.
During a period from March to May of that year, an outbreak of S. agona occurred in Paragould,
Arkansas. In total, seventeen people were infected. The source was traced back to a local
restaurant which had received poultry products from a Mississippi farm that had used fish meal
contaminated with S. agona (Franco, 2006).
From 1965 to 1970, the animal health division of the United States Department of
Agriculture (USDA) collaborated with the Federal Drug Administration (FDA) to sample animal
by-products and finished meals to determine levels of Salmonella contamination. In response to
some of the initial findings, Commissioner Goddard made the decision within the FDA to
include food produced for animal consumption as part of Section 201 (f) of the Federal Food,
Drug and Cosmetic Act in 1967. This meant that Salmonella contamination in animal feed was
now considered an adulterant by definition of the Act (Franco, 1999).
While studies have indicated that Salmonella can be detected in finished animal byproducts, the amount present after processing declines rapidly. Sutton et al. (1992) demonstrated
that in a sample of MBM stored at 28.8°C, Salmonella levels decrease from 30 CFU/g to below
the detection limit within 2 days of storage. Even when Salmonella is present, animal byproducts still pose less of a risk for Salmonella contamination when compared to meals
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composed of vegetable proteins. Hamilton (2002) determined the incidence rate of Salmonella in
animal by-product meals was higher in the Netherlands, Canada, and the U.S., while the levels
were higher in the vegetable proteins in Germany and the UK. The highest incidence rates for
both proteins were observed in products produced in the U.S. While the animal proteins had a
higher range of incident rates, the risk factor associated with vegetable proteins is higher due to
the fact that makes up a larger percentage of the finished feed. The animal proteins have a risk
factor of 0.9-1.68 and vegetable proteins have a risk factor of 1.743-8.964 for Salmonella
(Hamilton, 2002)
The establishment of linkages between human disease and contaminated animal byproducts along with the FDA’s incorporation of animal feed into the definition of food led to the
rendering industry began placing a higher emphasis on the biological safety of the products they
produce. In 1984, the rendering industry founded the Animal Protein Producers Industry (APPI)
to regulate biosecurity within the industry, such as Salmonella screening or developing protocols
such as hazard analysis and critical control plans (HACCP) to ensure the safety of the product,
and to continuously educate the industry on new issues that may impact their products (Franco,
2006).
Since the formation of APPI, vast improvements have been made to the rendering process
and more recent studies have provided data that indicates finished meals are free of pathogenic
bacteria including Salmonella as it leaves the cooker. Troutt et al. (2001) tested raw products
used in production at 17 rendering facilities in the mid-western United States. The results
showed there were high levels of Salmonella spp., Listeria monocytogenes, Campylobacter
jejuni, and Clostridium perfringens contamination. When the processed meals were tested, none
of these pathogens were detected (Table 1.3). In addition to bacteria, viruses are also effectively
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eliminated during the rendering process. The time and temperature used by the rendering
industry was always thought to be sufficient to kill viruses within the by-products. Pirtle (1999)
demonstrated this using pseudorabies virus (PRV, a common viral disease in pigs) as a model
microorganism. To determine the effectiveness of the rendering process, raw materials with
varying degrees of viral contamination were processed and the resulting MBM was analyzed for
the presence of the virus. The results indicated that the virus was unable to survive the rendering
process (Pirtle, 1999).
Table 1.3 Pathogen elimination from finished rendered products
Pathogen
Clostridium perfringens
Listeria spp.
Listeria monocytogenes
Campylobacter spp.
Campylobacter jejuni
Salmonella spp.

Raw Tissue
(% positive)
71.4
76.2
8.3
29.8
20.0
84.5

Finished Product
(% positive)
0
0
0
0
0
0

Troutt et al. (2001)

Two years after the establishment of the APPI (1986) BSE was confirmed in the United
Kingdom and believed to have originated from MBM produced from sheep by-products
(Kimberlin, 1990). This led to the USDA conducting an 8 year study in an attempt to
demonstrate that the rendering process kills the prions responsible for BSE and they are not
transmitted orally to cattle via consumption of finished MBM. Neonatal calves were fed a diet of
raw brain or finished MBM from sheep infected with scrapie. During the eight year period, the
calves were checked for signs of disease, lesions, or prion protein deposits associated with
scrapie or BSE (Cutlip et al., 2001). The results showed that experimental calves given the MBM
diet did not exhibit any clinical signs or develop lesions associated with BSE. In addition,
examination of spinal cord and brain samples did not indicate the presence of any prions (Cutlip
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et al., 2001). Howevere, a disease found in humans, Creutzfeldt-Jakob disease, linked to the
consumption of cattle suffering from BSE was identified a decade after the intial discovery of
BSE. This led to the FDA’s decision to ban the use of feed produced from ruminants as a feed
ingredient for ruminant animals (Franco, 2006).
While there are some risks associated with finished animal by-products, the rendering
process is still the best means for the disposal of the raw by-products and mortalities. The
rendering industry provides numerous advantages including: infrastructure, volume reduction,
controlled processing, established regulations, and timely processing (Hamilton et al., 2006). To
validate this claim, the United Kingdom Department of Health (2001) conducted a study
evaluating the risks involved with various methods of disposal for animal by-products. Their
study determined biological hazards were negligible if the material was treated by rendering,
incineration, or funeral pyre. While biological hazards were eliminated, incineration and pyres
create chemical hazards associated with burning. The rendering process was the only means of
disposal that successfully eliminated the biological and chemical hazards. The only exception
was BSE, which was found to be a negligible risk to humans if the solid material was incinerated
(Hamilton et al., 2006). A summary of the study can be seen in Table 1.4.
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Table 1.4 Potential health risks of various methods of animal by-products disposal1
Disposal Options
Disease/Hazardous
Agent
Rendering Incineration
Landfill
Pyre
Campylobacter, E. coli,
Listeria, Salmonella,
Bacillus anthracis,
C. botulinum,
Leptospira,
Mycobacterium
tuberculosis var bovis,
Yersinia

Burial

very small

very small

moderate

very small

high

Cryptosporidium,
Giardia

very small

very small

moderate

very small

high

Clostridium tetani

very small

very small

moderate

very small

high

Prions for BSE, scrapie

moderate

very small

moderate

moderate

high

Methane, CO2
Fuel-specific chemicals,
metal salts

very small

very small

moderate

very small

high

very small

very small

very small

High

very small

Particulates, SO2, NO2,
nitrous particles

very small

moderate

very small

high

very small

PAHs, dioxins

very small

moderate

very small

high

very small

Disinfectants, detergents

very small

very small

moderate

moderate

high

Hydrogen sulfide

very small

very small

moderate

very small

high

Radiation

very small

moderate

very small

moderate

moderate

1 (U.K. Department of Health 2001)

In addition to potential biological and/or chemical hazards, the other mean of disposal
can simply not handle the volume of raw materials. When the by-products are disposed of in
landfills, an additive such as saw dust is mixed in to reduce high moisture content in raw
materials. The addition of saw dust can raise the volume of material by 25% to a point that
disposing of all the animal by-product and mortalities generated in 1 year would consume of
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25% of the total landfill space in the United States (Sparks, 2001). Another alternative for
disposal of animal by- products is composting, but composting is limited to small scale
production due to the amount of material need to balance the carbon and nitrogen ratio and
moisture content in the raw by-products and mortalities (Hamilton et al., 2006). Based on the
pork industry alone, a space of ca. one trillion cubic feet would be needed to compost the amount
of material rendered each year (Glanville, 2001). While effective at eliminating biological
hazards, incineration is also limited by the volume of raw by-products produced each year. The
volume of raw material would require large amounts of fossil fuel which is also cost prohibitive.
In addition, the ash produced from the raw by-products would have to be disposed of as well
(Hamilton et al., 2006).
This literature review will focus mainly on the microbiological safety of the rendered
products. Two microbial species, Enterococcus and Salmonella, will be discussed in detail in the
following sections.
Enterococci: General Overview
Enterococci are ubiquitous and found in most environments, but most commonly they
can be isolated from an animal’s alimentary tract, the soil, water, and food. They have acquired
many attributes that ensures their survival in such diverse environments including heat tolerance
up to 45°C (higher in certain species), tolerance of high salt concentrations and a broad range of
pH levels. In addition to these characteristics, the enterococci are commonly multi-drug resistant
which has allowed them to persist with in an animal host (Facklam et al., 2002). The common
presence within the alimentary tract of livestock and its ability to survive in various
environments makes enterococci a concern for finished rendered meals. Like Salmonella, there is
an opportunity for enterococci contamination of rendered animal meals due to cross-
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contamination with the incoming raw material (Ockerman and Hansen, 1988). Once in the feed,
enterococci can enter the food chain. While most strains of enterococci lead to treatable or selflimiting diseases, there is a major concern for vancomycin resistant enterococi (VRE), which
will be discussed in more detail later.
Thiercelin (1899) first reported what is now thought to be enterococci in human fecal
samples. He described the bacterium as appearing in pairs or short chains. Andrews and Horder
(1906) identified a bacterium of fecal origin, Streptococcus faecalis, which would clot milk.
Thirteen years later. Orla-Jensen (1919) identified an organism with different fermentation
patterns, which was Streptococcus faecium. A third bacterium, Streptococcus durans, of fecal
origin was discovered by Sherman and Wing (1935, 1937) with less fermentation activity. In
1967, a new species Streptococcus avium was added to the group by Nowlan and Deibel (1967).
Kalina (1970) proposed a new genus name, Enterococcus, should be established. Genetic
evidence provided by Schleiter and Kilpper-Balz (1984) showed that S. faecalis and S. faecium
were significantly different from other member of the Streptococcus genus resulting in the
formation of the new genus, Enterococcus.
Disease, Virulence, and Antibiotic Resistance of Enterococci
While enterococci do inhabit the gastrointestinal tract of the majority of humans, they are
still responsible for a wide variety of diseases. Enterococci have been linked to endocarditis
(MacCallum et al., 1899; Rantz and Kirby, 1943; Megran, 1992), respiratory tract infections
(Rantz and Kirby, 1943), and urinary tract infections (Braude, 1973; Gross et al., 1976; Richards
et al., 2000; Rantz and Kirby, 1943; Rantz, 1942). The most common species associated with
human illnesses are E. faecalis and E. faecium; however, the following species have also been
linked to human disease: E. avium, E. casseliflavus, E. durans, E. gallinarum, and E. raffinosus
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(Murray, 1990). Recently, enterococci have been identified as the leading cause of surgical site
infections (17.1%), second leading cause of blood stream infections (11.5%), and the third
leading cause of nosocomial urinary tract infections (14.3%) (Richards, 2000). In particular, E.
faecalis accounts for up to 80% of the nosocomial infections resulting from enterococci (Huycke
et al., 1998; Sahm, 2000).
The high incidence of enterococci infections can be partially attributed to a large set of
virulence factors. For example, E. faecalis is capable of producing the enzymes cytolysin,
gelatinase, and serine protease which play a role in host tissue degradation (Hancock and
Gilmore, 2000; Dupont et al., 1998; Burns et al., 1996; Okamoto et al., 1997; Plaut, 1983;
Prokesova et al., 1992; Schultz and Miller, 1974; Sundqvist et al., 1985; Lantz et al., 1991;
Travis et al., 1994). The Enterococcus genus is also capable of producing an aggregation
substance (Clewell, 1993) and Enterococcal surface protein (Esp) (Shankar et al., 2001) which
aid in conjugation and adherence to epithelial cells, respectively. Enterococci may also be
surrounded by a capsule allowing them to evade phagocytosis (Gilmore, 2002). Enterococcci
also produce large amounts of superoxide. The superoxide fragments the chromosome of
epithelial cells in the colon granting the enterococci entrance into the bloodstream (Huycke et al.,
1996; Huycke et al., 2001).
In addition to the treatment of human infections, antibiotics have other applications such
as animal growth promoters. There are four primary applications for antibiotics in food animals.
The first is the therapeutic treatment of infections within the animal. The second use is for the
treatment of a healthy animal living in a flock where at least one animal is infected in an effort to
prevent infection. A third use is as a prophylactic way to treat animals to prevent the occurrence
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of disease. The final means is as a growth promoter, which prevents the animal from having to
fight off infection and the growth of the animal will improve (Aarestrup, 2002).
The Union of Concerned Scientists estimated that in the United States 24.6 million
pounds of antimicrobial agents are used on feed animals every year compared to the 3 million
pounds used for human treatment (Mellon et al., 2001). Similarly, the European Agency for
Evaluation of Medical products reported that in 1997 that ca. 10 million pounds of antimicrobial
agents were used for feed animals across Europe (EMEA, 1999).
While enterococcal infections are rarely treated in animals, enterococci are persistently
present within the animal’s intestinal tract. These enterococci are then constantly exposed to an
antimicrobial agent when it is being used as a growth promoter or prophylactic, which could lead
to the selection of strains resistant to the antimicrobial agent used (Aarestrup, 2002). Starr and
Reynolds (1951) demonstrated this possibility with coliforms in the intestinal tracts of turkeys
being continually fed feed supplemented with streptomycin. Their results indicated the presence
of streptomycin resistant coliforms. Two other studies also demonstrated that the use of
tetracycline as a growth promoter selected for resistant strains of group D streptococci,
enterococci, within chickens (Barnes, 1958; Elliot and Barnes, 1959).
Due to the overuse of antibiotics as growth promoters, enterococci have developed high
levels of resistance to various classes of antibiotics including aminoglycosides, chloramphenicol,
glycopeptides, macrolides, streptogramin, and tetracycline. Several studies have idenitified
enterococci resistant to one or more of these classes (Table 1.5).
The antimicrobial agents used for therapy and growth promotion in these feed animals
are essentially identical to the classes of antibiotics used for human treatment (Aarestrup, 2002).
This causes concern that the antimicrobial agents used in growth promotion can results in a
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decrease in efficiency of those used for human treatment. This concern was first acted upon in
1969 by the Swann committee (Swann, 1969). The committee developed a report recommending
that any antibiotic used as a method of treatment not be used for growth promotion. This
recommendation was partially adopted by the European Union, but the United States continued
using antibiotics such as penicillin in large amounts (Aarestrup, 2002). The antibiotic avoparcin,
which is in the glycopeptide class, was banned from use as a growth promoter in Denmark in
1995 due to concerns that it would select for enterococci resistant to vancomycin and that these
resistant strains could then spread to the human population. This led to a complete ban of
avoparcin in all countries within the European Union in 1997. A year later, virginiamycin was
banned due to cross resistance with quinupristin/dalfopristin. The antibiotics bacitracin,
spiramycin, and tylosin were also banned as growth promoters in 1998 by the European Union
(Aarestrup, 2002).
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Table 1.5 Reported cases of antibiotic resistant enterococci in food animals1
Class
Antibiotic
Enterococcus spp.
Summary
faecalis
22% chicken meat samples
Aminoglycosides Gentamicin
Gentamicin
faecalis
11.5% broiler
Kanamycin
faecalis and faecium
30% bovine mastitis
Kanamycin
faecalis
62% chickens and 36% swine
Streptomycin
faecalis and faecium
80% bovine mastitis
Streptomycin
faecalis
64% chickens and 57% swine
Streptomycin
faecium and faecalis
14.4% and 67.9% broilers
faecium
1% broilers and 7% swine
Chloramphenicol Chloramphenicol
Chloramphenicol
faecalis
2% broilers and 4% swine
Chloramphenicol
faecium and faecalis
40% raw meat samples
Chloramphenicol
faecalis
2.6% broilers
Erythromycin
faecium
12.7% broilers and 46.7% swine
Macrolide
Erythromycin
faecalis
28.1% swine
Erythromycin
faecium and faecalis
65.3% and 89.7% broilers
Tylosin
faecalis
50% poultry
Tylosin
faecium
67% poultry
Tylosin
faecium and faecalis
65.4% and 89.7% broilers
Tylosin
faecium
75.4% broilers and 81.8% swine
Tylosin
faecium
82% broilers and swine
Tylosin
faecalis
54% broilers and 86% swine
Quinupristin/dalfopristin faecium
79% broilers and 60% swine
Streptogramin
Quinupristin/dalfopristin faecalis
90% broilers and 98% swine
Quinupristin/dalfopristin faecium
51.2% poultry cloacal swabs
93% poultry carcass
Quinupristin/dalfopristin faecium
Quinupristin/dalfopristin faecium
23% 24 day old turkey
Quinupristin/dalfopristin faecium
100% 130 day old turkey
Virginiamycin
faecium
33.9% broilers and 22.5% swine
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Ref.
Thal et al., 1995
Yoshimura et al., 2000
Jayorao and Oliver, 1992
Rollins et al., 1985
Jayorao and Oliver, 1992
Rollins et al., 1985
Yoshimura et al., 2000
Aarestrup et al., 2000a
Aarestrup et al., 2000a
Pavia et al., 2000
Yoshimura et al., 2000
Aarestrup et al., 2001
Aarestrup et al., 2001
Yoshimura et al., 2000
Dutta and Devriese, 1982
Dutta and Devriese, 1982
Yoshimura et al., 2000
Aarestrup et al., 2000b
Butaye et al., 2001
Butaye et al., 2001
Aarestrup et al., 2000a
Aarestrup et al., 2000a
Hayes et al., 2001
McDonald et al., 2001
Welton et al., 1998
Welton et al., 1998
Aarestrup et al., 2001

Tetracycline

Virginiamycin
Virginiamycin
Tetracycline
Tetracycline
Tetracycline
Tetracycline
Oxytetracycline
Oxytetracycline

faecium
faecalis
faecium
faecium
faecalis
faecium and faecalis
faecium
faecalis

1 (Gilmore, 2002)
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75% broilers and 85% swine
95% broilers and 99% swine
20% broilers and 70% swine
32% broilers and 63% swine
59% broilers and 68% swine
94.8% and 93.6% broilers
92% broilers and 97% swine
79% broilers and 100% swine

Aarestrup et al., 2000a
Aarestrup et al., 2000a
Aarestrup et al., 1998
Aarestrup et al., 2000a
Aarestrup et al., 2000a
Yoshimura et al., 2000
Butaye et al., 2001
Butaye et al, 2001

Vancomycin Resistant Enterococci
Enterococci have also developed high levels of resistance to the glycopeptides.
Resistance was first detected in E. faecium clinical isolates from France in 1986 (Leclerq et al.,
1988) and the United Kingdom (Utley et al., 1989). The first detection of glycopeptide resistant
enterococci (GRE) outside of a clinical setting was the occurrence of the vanA phenotype of
vancomycin resistance in the sewage and among chickens in the United Kingdom (Bates et al.,
1993). As mentioned previously the use of the growth promoter avoparcin was identified as the
cause of the spread of GRE. Fecal samples collected from farms using avoparcin as a growth
promoter contained high levels of GRE; whereas, samples from farms not using avoparcin were
only rarely contaminated with GRE (Aarestrup, 1995; Bayer et al., 1997; Klare et al., 1995). The
presence of GRE in food animals has become widespread in Europe (Gilmore, 2002). Aarestrup
(1998a) detected glycopetide resistance in 70% and 20% of the E. faecium isolates collected
from broilers and pigs, respectively, in Denmark. Reports from the Netherlands have indicated
that 34% and 80% of the enterococci isolated from the feces of pigs and broilers, respectively,
are GRE (Van den Bogaard et al., 1997). While the presence of GRE in Europe has been well
documented, there have been no reports of GRE in the US, where avoparcin is not used (Coque
et al., 1996).
Vancomycin is a glycopeptide antibiotic that is used to treat infections resulting from
antibiotic resistant gram positive bacteria. The first reported cases of vancomycin resistant
enterococci (VRE) were in E. faecium isolates collected from patients with leukemia in France
and Patients in England suffering from renal failure (Leclerq et al., 1988; Uttley et al., 1988).
The occurrence of VRE is not limited to Europe. Fridkin and Gaynes (1999) reported that over
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20% of enterococci isolates collected in 1998 in the US were VRE. In some hospitals, E. faecium
has been reported as resistant to vancomycin over 90% of the time (Kak and Chow, 2002).
The emergence of VRE has been attributed to the widespread use of the antibiotic in
clinical settings and the use of glycopeptides as growth promoters in animal feed. The variety in
VRE genotypes and their sequence variability implies that they did not emerge as a single point
mutation (Kak and Chow, 2002). The guanine (G) & cytosine (C) content exhibited in vanA and
vanB type VRE exceeds that typically found in either E. faecalis or E. faecium, implying that
VRE probably acquired gene cluster from other microorganisms (Patel,1999). The proposed
theory of evolution is that the gene cluster responsible for resistance was transferred from
vancomycin producing organisms to a specific organism with a similar G & C content. These
organisms then transferred the gene clusters to enterococci. Once enterococci had gained
resistance, the occurence of resistance grew due to the abundant use of glycopeptides. In the US,
the problem is more concentrated in clinical settings. The occurrence of VRE in Europe is mostly
concentrated in non-human hosts and within healthy humans. The reasons for these patterns can
be contributed to the difference in primary use of glycopeptides between the two regions. In the
US, glycopeptides have primarily been used as human therapy while in Europe they have been
largely used as growth promoters in feed animals (Kak and Chow, 2002).
Vancomycin works by inhibiting the synthesis of the cell wall within gram positive
bacteria. Specifically, the glycopeptides binds to the D-alanine-D-alanine terminus of the
pentapeptide side chains within the cell wall. Once bound, the drug prevents the formation of
hydrogen bonds that bind the peptide side chains to each other. This prevents the cross-linking of
the peptidoglycan chains leading to a loss in the structural integrity of the cell wall resulting in
cell death (Arthur and Courvalin, 1993; Reynolds, 1989; Walsh et al., 1996).
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Resistance to vancomycin in enterococci results from a modification in the composition
of the pentapeptide side chains. The D-alanine-D-alanine terminus is replaced by a terminus
composed of either D-alanine-D-lactate or D-alanine-D-serine. The substitution with D-lactate
decreases the results in a 1000x decrease in the affinity for vancomycin due to the loss of a
hydrogen bond (Bugg et al., 1991). In contrast, the substitution with D-serine only results in a 7x
decrease in affinity for vancomycin (Billot-Klein et al., 1994).
Six gene clusters have been identified as mediators of vancomycin resistance in
enterococci (Table 1.6). Five have been identified as acquired traits, while one gene (vanC) is
intrinsic. The mechanisms for resistance are genotypically and phenotypically distinct for each
gene cluster involving a complex group of enzymes. These enzymes are responsible for detecting
the presence of vancomycin, initiating the change in peptidoglycan side chain production to a
resistant state, and to eliminate the normal (sensitive) peptide-side chain precursors (Kak and
Chow, 2002).
Table 1.6 VRE Genotypes1
Vancomycin
Teicoplanin
Genotype MIC (µg/ml)
MIC
vanA
64-1000
16-512

Expression
inducible

Precursor
Species
D-Ala-D-Lac E. faecalis, E.
faecium,
and 7 others
D-Ala-D-Lac E. faecalis and
E. faecium

vanB

4-1000

≤1

inducible

vanC

2-32

≤1

constitutive
inducible

D-Ala-D-Ser

vanD

64-128

4-64

constitutive

D-Ala-D-Lac E. faecium

vanE

16

0.5

inducible

D-Ala-D-Ser

E. faecalis

vanG

<16

<0.5

?

?

E. faecalis

1 (Gholizadeh and Courvalin 2000)
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E. casseliflavus,
E. gallinarum,
and E. flavescens

The vanA cluster is characterized by high levels of induced resistance to vancomycin
(≥64 µg/ml) and teicoplanin (≥16 µg/ml). Typically, enterococci acquire this gene cluster
through the incorporation of the Tn1546 transposon or from a Tn3 transposon (Arthur, 1993a;
Brisson-Noel et al., 1990). Like the vanA cluster, the vanB cluster also confers high levels of
resistance to vancomycin, but vanB does not confer resistance to teicoplanin (Evers et al., 1994;
Evers et al., 1993; Quintilions et al., 1993; Williamson et al., 1989). While vanB is typically
present within the chromosome, it can also be carried on plasmids (Rice et al., 1998). Studies by
Quintilioni et al. (1996; 1994) have demonstrated that the vanB gene cluster can be transferred
between enterococci via the Tn1547 transposon. In addition, Carlos et al. (1998) demonstrated
that the vanB gene cluster was transmitted simultaneously as induced ampicillin resistance via
the Tn5382 transposon. The vanC gene cluster is only found within the motile species of
enterococci and confers low levels of resistance to vancomycin. The specific genes encoding
vanC type resistance are dependent upon the bacterial species. It is encoded for by the vanC-1
gene in E. gallinarum, vanC-2 in E. casseliflavus, and vanC-3 in E. flavescens (Clark et al.,
1998; Dutka-Malen et al., 1992; Leclerq et al., 1992; Navarro and Courvalin, 1994). The vanD
gene cluster confers intermediate levels of resistance to both vancomycin and teicoplanin. Unlike
the previous gene clusters, vanD is located on the chromosome and is non-transferable
(Casadewell and Courvalin, 1999; Perichon et al., 1997). Both the vanE and vanG confer low
levels of vancomycin resistance, can be transmitted, and are inducible (Fines et al., 1999;
McKessar et al., 2000).
The vanA operon is composed of seven genes (Table 1.7). The first set of genes (vanH,
vanA, and vanX) is directly involved in glycopeptides resistance. The second set (vanR and vanS)
regulate resistance, while the vanY gene is responsible for the removal of normal cell wall
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precursors. The function of the seventh gene, vanZ, is still unclear (Kak and Chow, 2002).
Resistance is initiated by the transmembrane segment of vanS (protein kinase) which is
responsible for sensing the presence of glycopeptides. After sensing the glycopeptides, vanS
undergoes autophosphorylation which results in the transfer of a phosphoryl group to vanR, the
response regulator. The activated vanR then activates vanH by binding to its promoter region. It
also bind to its own promoter region leading to further transcription of both the vanR and vanS
genes (Arthur, 1992b). The vanH protein then begins the process of D-Ala-D-Lac production by
reducing pyruvate to D-Lac (Arthur, 1992a). The ligase, vanA, then bind the D-Lac to a D-Ala.
The newly formed D-Ala-D-Lac are then bound to UDP-N-acetyl muramide to be incorporated
into the peptidoglycan layer. The D-Ala-D-Ala components of the tetrapeptide side chains are
then removed by vanX, a dipeptidase (Reynolds et al., 1994). VanY finishes the process by
removing any remaining D-Ala-D-Ala precursors that were missed by vanX (Arthur et al., 1998).
The vanB operon has similar components that function the same way as in vanA. The
exceptions is that vanB contains a vanW gene instead of a vanZ gene, but like vanZ its function is
unknown (Quintiliani et al., 1993). The vanD operon differs in the fact that the vanY
carboxypeptidase is sensitive to penicillin and the vanX dipeptidase has little function (Kak and
Chow, 2002). VanE operons produce D-Ala-D-Ser subunits rather than D-Ala-D-Lac like vanA
(Fines et al., 1999; Aries et al., 1999). The less studied vanG operon is composed of 7 open
reading frames which are believed to lead to the production of D-Ala-D-Ser subunits in a matter
similar to vanC and vanE (McKessor et al., 2000)
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Table 1.7 vanA Operon Genes and their Functions1
Gene
Protein
Function
vanH dehydrogenase
converts pyruvate to lactate
vanA Ligase
ligates alanine to lactate to form D-Ala-D-Lac
vanX Dipeptidase
breaks the D-Ala-D-Ala dipeptide that may have formed
vanY carboxypeptidase
hydrolysis of any D-Ala-D-Ala pentapeptide precursor
vanR response regulator activates transcription of the resistance pathway
vanS protein kinase
senses presence of glycopeptides and phosphorylates VanR
1 (Gholizadeh and Courvalin 2000)

Enterococci Non-Human Reservoirs and Occurrence in Rendered Products
Although, enterococci are found in numerous environments, patterns in the distribution of
a particular species do exist (Aarestrup, 2002). Winslow and Palmer (1910) studied the
distribution of streptococci, including enterococci, in humans, horses, and cows in an effort to
determine the source of fecal contamination in public water supply. While there were certain
species found within all three hosts, the most commonly isolated species from the farm animals
were E. faecalis, E. faecium, E. hirae, and E. durans. Other less common enterococcal species
are typically found in a distinct host species, e.g. Enterococcus columbae from pigeons. The
colonization of Enterococcus within chickens has a distinct age dependent pattern. Younger
chicks are mostly colonized by E. faecalis, but as the chicks age the E. faecalis is rapidly
replaced by E. faecium, E. hirae, E. cecorum, and E. durans (Devriese et al., 1987, 1991; Kaukus
et sl., 1987). Similar colonization patterns by species have been reported in cattle as well. Pre
ruminant calves typically contain E. faecalis, E. faecium, and E. avium, which are gradually
replaced by E. cecorum. The overall Enterococcus population level diminishes as the cattle age,
and typically, the feces of adult cattle show little to no presence of enterococcal species
(Devriese et al., 1992).
Enterococci are a common contaminant of animals used to produce rendered animal
meals (beef, poultry, and pork) (Franz et al., 2003). For example, Knudtson and Hartman (1993)
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detected levels of 4-8 log CFU/cm3 on pig carcasses, with E.faecalis and E. faecium as the
dominant species. While there has been little work in the detection of enterococci in finished
rendered animal meal, the common occurrence in the animals used as raw material and
enterococci’s elevated heat tolerance could potentially result in contamanitation of the finished
meal. Cullen et al. (2003) and Schwalbe et al. (1999) both demonstrated that enterococi can be
isolated from finished rendered meals. In 2003. The FDA conducted a national survey, and
enterococci was identified in 84% of the meal samples collected with the highest level of
incidence in MBM and E. faecium being the dominant species (Cullen et al., 2003).
Salmonella: Overview
Salmonella spp. are gram-negative, bacillus shaped, facultative anaerobic, and motile
members of the Enterobacteriaceae family. A list of other biochemical characteristics can be seen
in Table 1.8. Typically, Salmonella are identified by the fermentation of glucose into gas and
acid on triple sugar iron (TSI) medium and will not utilize sucrose or lactose in differential
media (Andrews et al., 1994; D’Aoust and Purvis, 1998). While typical Salmonella do not utilize
sucrose or lactose, Le Minor et al. (1974; 1973) have demonstrated in some cases sucrose and
lactose fermentation can be mediated by plasmids.
The nomenclature has changed several times during the 20th century due to biochemical
and serological characteristics as well as DNA homology. Advances in the detection of the
somatic (O) and flagellar (H) antigens allowed the genus to be split into different “groups” (Le
Minor, 1981). This antigenic means of classification was first proposed by White in 1926.
White’s system of classification was further expanded upon by Kauffman in 1941 giving the
modern day Kauffman-White classification system which currently includes over 2,541 different
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serovars of Salmonella (Popoff et al., 2004). A complete detailing of the changes in
nomenclature can be seen in Table 1.9.
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Table 1.8 Biochemical characteristics of Salmonella spp.1
Biochemical Test
Glucose Lactose Sucrose Oxidase Catalase Citrate H2S Lysine Ornithine Urea
Result
+
+
+
+
+
+
1 (D'Aoust and Maurer, 2007)

Table1.9 Taxonomy of Salmonella1
Diagnostic basis
Features
Biochemical
Five subgenera (1-V)

Serovar Nomenclature
S. typhimurium

Reference
(Kauffman, 1966)

Biochemical

Three species (S. typhi, S. choleraesuis,
S. enteritidis) Arizona is separate genus

S. enteritidis serovar
Typhimurium

(Ewing, 1972)

DNA homology

Single species (S. choleraesuis)
Seven subspecies (choleraesuis, salamae,
arizonae, diarizonae, houtenae,
bongori,indica)

S. choleraesuis subsp.
Choleraesuis
serovar Typhimurium

(Le Minor et al., 1986)

DNA homology

Single species (S. enterica)
Seven subspecies (choleraesuis, salamae,
arizonae, diarizonae, houtenae,
bongori,indica)

S. enterica subsp. Enterica
serovar
Typhmurium or Salmonella
serovar
Typhimurium

(Le Minor and Popoff, 1987)

Multilocus enzyme
electrophoresis

Two species (S. enterica [six subspecies] and
S. bongori)

S. enterica subsp. Enterica (I)

(Reeves et al., 1989)

1 (D'Aoust and Maurer, 2007)
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Salmonella Occurrence and Presence in Rendered Products
Salmonella continues to be a prominent foodborne pathogen in the human food chain due
to its widespread distribution in the natural environment, within the meat (beef, poultry, fish, and
shellfish) industry, and the recycling of inedible animal parts (offal) into animal feed (D’Aoust,
1989; D’Aoust 1994). To address this issue, the Food Safety Inspection Service (FSIS) with the
USDA published the “Final Rule on Pathogen Reduction and Hazard Analysis and Critical
Control Point (HAACP) Systems” in 1996. This document required the meat industries to
implement HAACP plans and to take regular samplings to detect the indicator organism
Escherichia coli biotype I, while the FSIS collected regular samples to determine if the
implemented HAACP plans were sufficiently reducing Salmonella levels. Prior to the release of
the “Final Rule”, data indicated that broiler chickens were contaminated with Salmonella ca.
24% of the time. In 1999, broiler Salmonella contamination levels had been reduced to ca. 11%;
however, the rate has gradually increased since 1999 reaching ca. 16% in 2005 (D’Aoust and
Maurer, 2007).

Aside from the raw materials, it is possible for the environmental surfaces to contaminate
the final products upon contact. Stainless steel, cement, rubber, and high density polyethylene
plastic are materials found inside a rendering facility. Kusumaningrum et al. (2003) has
demonstrated that Salmonella is capable of adhering to stainless steel. While low inoculum levels
of S. Enteritidis (10 CFU/cm2) were undetectable on the steel after 1 h. A high inoculum of
Enteritidis (105 CFU/cm2) was detected after 96 h. that the presence of Salmonella on rubber
conveyor belts was documented on a Danish pig farm. A rubber conveyor belt was used to
transport the manure from the piggery to an on-site manure dump. S. Typhimurium isolates
collected from this conveyor belt were identical to Typhimurium isolates that were detected 20
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months earlier during the first isolation (Sandvang et al., 2000). It is possible that this strain has
been persistent on the conveyor belt and is continuously passed between the manure dump and
piggery. The presence of food residues increased the survival time of the bacteria. S. Enteritidis
can be transferred from the steel to food (Kusumaningrum et al., 2003). The study tested the
bacterial transfer to cucumber slices and chicken filets by steel immediately after contamination
or 15 minutes after contamination. Directly after contamination, contamination rates were as
high as 105 ± 28% for cucumber slices and 94 ± 42% for chicken filets. When the contamination
was allowed to sit for 15 minutes, the transfer rates were reduced to 90 ± 27% for cucumber
slices and 55 ± 21% for the chicken filets.
Salmonella spp. are capable of producing biofilm on environmental surfaces (Jones and
Bradshaw, 1996). Salmonella Weltevreden formed biofilms on high density polyethylene plastic,
cement, and stainless steel with the following cell densities: 3.4 x 107, 1.57 x 106, and 3 x 105
CFU/cm2, respectively (Joseph et al., 2001). The same environmental materials can be found in a
rendering facility; therefore, Salmonella biofilms can act as a continuous source for crosscontamination between contact surfaces and products.
A study conducted by Weigel et al. (1999) revealed some potential sources of the
Salmonella contamination in animal feed on an Illinois swine farm. During the study, one
hundred samples of feed were collected and only 2% were contaminated with Salmonella. In
addition to the feed, samples were collected from the worker’s boots, water, the floor, cats in the
area, mice on the farm, and flies. The boots of the workers had the highest rate (17.2%, n=93) of
Salmonella contamination, while the flies and the flooring had the lowest levels of contamination
at 7.4% (n=95) and 7.9% (n=471), respectively. All of these mentioned factors could the
potentially serve as a source for cross-contamination.
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Salmonella has been identified as a common contaminant of rendered animal products.
This has been reported in meat (81%) and feather meal (40%) by Hacking et al. (1977), Loken et
al. (1968), and Beumer (1997) reported Salmonella contamination in sampled rendered products
with incidence rates of 17% and 3.2-7.6%, respectively. The FDA conducted two separate
studies in 1993 and 1994 to test for the presence of S. enterica, with Salmonella positive rates of
56% and 25%, respectively (McChesney et al., 1995; Crump et al., 2002). The Animal Protein
Producers Industry (APPI) has collected weekly samples from the rendering processing plant and
tested for the presence of Salmonella. The average incidence rate was reported as 25% (Franco,
2005). During one particular testing year, four serotypes commonly associated with food borne
illness (Typhimurium, Enteritidis, Agona, and Infantis) were isolated with the prevalence rates of
0.5, 0.5, 3.0, and 3.5% of the samples, respectively. In addition, human Salmonella infection has
been linked to the contaminated animal feed (Crump et al., 2002). Knox et al. (1963) established
a connection to a S. Heidelberg outbreak from contaminated milk to meat and bone meal used in
the feed supplied to the milk-producing cattle.
Salmonella: Survival Adaptations
Salmonella spp. are capable of adapting to numerous environmental stresses including
extreme temperatures (high and low), a wide range of pH values, and low water activity (aw)
levels. Some strains of Salmonella have been able to grow in environments as high as 54°C and
as low as 2°C (D’Aoust et al., 1975). Angelotti et al. (1961) detected Salmonella in custard and
chicken a la king that had been heated to 45.6°C. Droffner and Yamamoto (1992) determined
that a strain of S. Typhimurium was capable of mutating to survive at 54°C after prolonged
exposure to thermal stress. The mechanism behind this resistance has not been determined, but
the mutation has been determined to occur in the ttl gene or the mth gene which gives resistance
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up to 48° and 54°C, respectively. In addition to these genes, other environmental factors play a
role in the level of heat resistance. For example, heat resistance has been shown to increase as a
result of a decrease in the aw of the substance (D’Aoust, 1989). Goepfert demonstrated that when
the substrate’s aw was reduced to a level of 0.90 by sucrose or glycerol, the S. Typhimurium had
D-values at 57.2°C of 40-55 minutes and 1.8-8.3 minutes, respectively. Other factors that
determine the level of heat resistance acquired include the nutrients available in the growth
environment, the phase of growth the cells are in, and the moisture level of the environment it
was isolated from (Goepfert et al., 1970; Kirby and Davies, 1990; Ng et al., 1969). Salmonella
can also become heat resistance through continuous exposure to higher sub-lethal temperatures, a
heat shock phenomenon. Exposing Salmonella cells to temperatures ≤50°C for 15-30 minutes
results in the production of heat shock proteins that confer higher levels of heat resistance
(Humphrey et al., 1993; Mackey and Derrick, 1990; Mackey and Derrick, 1986). The fate of
Salmonella under freezing temperatures is dependent on the matrix it is suspended in, the
kinetics of the freezing process, the physiological state of the bacterial cells before freezing, and
the particular serotype involved (Corry, 1971).
In addition to growing or surviving under temperature extremes, Salmonella can adapt to
a wide range of pH levels from 4.5 to 9.5 with an optimal range of 6.5 to 7.5. S. Typhimurium
has been shown to acquire high levels of acid tolerance through repeated exposure to mildly
acidic environments (ph 5.5-6.0). These exposed cells could then be transferred to a more acidic
environments (pH ≤4.5) resulting in a complex acid tolerance reaction involving the production
of acid shock proteins, new outer membrane proteins, reduced growth rate, and pH homeostasis
which allows the cells to grow in environments with a pH of 3.0-4.0 (Foster and Hall, 1991;
Hickey and Hirshfield, 1990). Three systems have been described that confer increased acid
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tolerance to Salmonella spp. including: pH dependent and rpoS independent log phase acid
tolerance response (ATR), the pH dependent and rpoS independent stationary phase ATR, and
the pH independent and rpoS dependent stationary phase ATR.
Salmonella Infection and Disease
Salmonella infections have a wide array of symptoms depending on the serotype involved
including enteric fever, enterocolitis, and potential systemic infections. Enteric fever results from
infection with the typhoid or paratyphoid strains with symptoms including diarrhea, fever,
headache, and prostration (D’Aoust, 1991). Those infections caused by non-typhoid strains
typically results in enterocolitis which appears from 8 to 72 hours after infection. These
infections are usually self-limiting resulting in diarrhea and abdominal pain that can last for up to
5 days (D’Aoust, 1989). In certain cases Salmonella can result in the following chronic
conditions: aseptic reactive arthritis, Reiter’s Syndrome, and ankylosing spondylitis.
McCullough and Eisele (1951) observed that a high level of Salmonella contamination
(104-107 CFU/ml) was needed in egg nog to comprise an infectious dose; however, D’Aoust et
al. (1985) and Kapperud (1990) have both demonstrated that 1 to 10 cells can be an infectious
dose in food with a high solid fat content. A lower infectious dose is required in a food substrate
with a high fat content due to the potential protection offered against the acidic environment of
the stomach. Once inside the duodenum, the lipids compromising the fat would disperse and the
Salmonella would be free to attach to the small intestine.
The first step of infection begins when Salmonella cells attach and then enter the
epithelial cells (enterocytes) lining the intestinal tract and the M cells that overly the Peyer’s
patches. Attachment is brought on by the interaction between type 1 (mannose-sensitive) or type
3 (mannose resistant) fimbriae adhered to host receptors which are located on the microvilli or to
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the glycocalyx surrounding the surface of the intestinal cells (D’Aoust, 1991, Polotsky et al.,
1994). Upon contact with the epithelial cells, proteinaceous appendages form on the surface of
the Salmonella cells (Galan and Ginnochio, 1994; Ginnochio et al., 1994). The production of
these appendages is energy dependent and they are shed once membrane ruffles are formed on
the attached epithelial cell (Ginnochio, 1994; Collazo et al., 1995). The attachment by the
Salmonella cells initiates a series of chemical signals between the invading Salmonella cell and
the host enterocyte or M cell (Garcia-del Portillo and Finlay, 1994; Ginnochio et al., 1994). The
invasion (inv) locus stimulates a calcium influx which results in a rearrangement of the
cytoskeleton within the host enterocytes and M cells (Finlay, 1994; Polotsky et al., 1994). The
influx of calcium ions is responsible for actin polymerization (Ruschkowski et al., 1992). In
addition to the calcium influx, the Salmonella cells also deliver the following invasion proteins
to the host cells: SipA, SipB, SipC, SptP, SopE2, and SopB (Collazo and Galan, 1997; Collazo et
al., 1995). Like calcium, these proteins stimulate the polymerization of actin into microfilaments
in the vicinity of the invading Salmonella cell (Galan and Zhou, 2000; Ginnochio et al., 1992).
Specifically, SipA and SipC act as catalyst for the polymerization of F-actin into microfilaments
(Hayward and Koronakis, 1999.; Zhou et al., 1999; Zhou et al., 1999a). SopE2 activates the
process of cytoskeleton rearrangement (Stender et al., 2000). The epithelial cell membranes
undergo “ruffling” by which the membrane stretches to surround and engulf the attached
Salmonella cell resulting in the bacterial cell entering the host epithelial cell via pinocytosis
(Jones et al., 1993). Once the Salmonella cell has invaded the host cell, SptP results in the
disruption of the host cell cytoskeleton returning into to its original state (Fu and Galan, 1998).
Once inside the cell, the Salmonella cell is initially confined inside a vacuole where it
will initiate its replication (Garcia-del-Partillo and Finlay, 1994). The vacuole then is transported
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through the cell, where it will eventually release the Salmonella cells into the lamina propria
(Isberg and Nhieu, 1994; Polotsky et al., 1994). The fimbriae surrounding the Salmonella’s
surface allows the cells to attach to host plasminogen which could greatly enhance the
invasiveness of that strain. Once attached, the plasminogen (zymogen) would likely be converted
to its active proteolytic form where it would allow the bacterial cell to easily breach through host
tissue barriers and penetrate into the deep tissues of the host (Sjobring et al., 1994).
Within the host cells, these Salmonella cells are capable of evading the host immune
system by preventing phagosome acidification (Alpuche-Aranda et al., 1994; Alpuche-Aranda et
al., 1992), avoiding lysosome fusion (Buchmeier and Heffron, 1991; Uchiya et al., 1999), or
preventing the maturation of phagolysosomes (Rathman et al., 1997). Evidence has also
demonstrated that Salmonella is capable of not only surviving inside phagolysomes but are
capable of replication inside them as well (Oh et al., 1996; Rathman et al., 1996). For example,
Salmonella produce several enzymes such as superoxide dismutase, peroxidase, and catalase that
protect them from the toxic oxygen products formed during the metabolic burst of phagocytes. In
total, there are 30 proteins produced in response to these toxic oxygen by-products (Popoff and
Noral, 1992). Salmonella cells may also have an additional system that protects them from
phagocytic cells referred to as the phoP/phoQ regulon (Miller, 1991; Popoff and Noral, 1992). It
is believed that these genes are responsible for producing chemical signals which alter the core
antigen component of the lipopolysaccharide (LPS) on the cell’s outer membrane (Vaara et al.,
1981) and provide resistance to antimicrobial peptides produced by neutrophils (Shafer et al.,
1984). The phoP/phoQ gene set is also responsible for the production of a cell surface protease
that degrades the defensins released by phagocytic cells (Guina et al., 2000).
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Salmonella: Traditional Chemical Control Methods
Since Salmonella is a continuous problem for the food industry, methods of sanitation
have been developed to reduced the risk of contamination in food products. Traditionally these
methods of sanitation have employed the use of chemical disinfectants to clean surfaces the
processed food may come in contact with. These chemicals have included chlorine based
compounds, iodine containing compounds, and quaternary ammonium compounds (Cramer,
2006; Hui et al., 2003; Marriot,1994; Guthrie, 1992).
Chlorine based compounds are used as either a liquid chlorine, hypochlorites, chlorine
dioxide, or inorganic and organic chloramines. The exact mechanism behind chlorine’s activity
is not clear but the following mechanism have been suggested: disruption of protein synthesis,
oxidative decarboxylation of amino acids, reactions with the nucleic acids, disruption of
metabolism by degrading enzymes, disruption of DNA, formation of toxic derivatives of
cytosine, and creation of chromosomal aberrations (Marriot, 1994). These chlorine based
compounds are corrosive and result in bleaching, so they must be used carefully around metals
and material susceptible to bleaching. The biggest drawback to chlorine based compounds in the
food industry is their affinity to bind to organic material. Once bound to this organic material the
compounds are inactivated, so higher concentrations in the range of 100 to 150 ppm are required
(Guthrie, 1992). The FSIS has required that animal slaughtering houses spray down their
equipment with a solution containing at least 200 ppm chlorine (Swacina, 1988).
There are three forms of iodine primarily used in food processing sanitation i.e.,
iodophors, alcohol-iodine solutions, and aqueous iodine solutions. The bactericidal activity has
not been studied in great detail but in general the iodine compounds release triciodide ions which
mix with acid to produce hypoiodous acid and diatomic iodine, which are the active
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antimicrobial forms (Marriott, 1994). Iodine containing compounds have drawbacks similar to
those of chlorine. They are corrosive to metal and have a high affinity for organic material,
which results in their inactivation. A positive aspect of these iodine-containing compounds is that
they react with microorganisms rapidly and are effective against a wide range of organisms.
These compounds are always mixed with detergents within an acid medium. The final solution
should contain between 25 to 50 ppm active iodine (Guthrie, 1992).
The major form of quaternary ammonium compounds is cationic detergents which inhibit
cell metabolic processes by inhibiting enzyme activity and cause the bacterial cells to leak
resulting in lysis. It is also known that when these compounds are added to a surface they form a
bacteriostatic film that is selective for particular microbes (Marriott, 1994). The quaternary
ammonium compounds have the advantage that they are not corrosive, but unlike the previous
two compounds, these quaternary ammonium compounds do not sufficiently work against gram
negative bacteria. These compounds also have some additional limitations including: they tend to
adhere to surfaces requiring excessive rinsing, they react with calcium and magnesium (cannot
be used in hard water), and they are incompatible with most soaps and detergents (Guthrie,
1992).
Another class of sanitizer is acids. Acids used most frequently for food processing
sanitation are the organic acids, such as acetic, peroxyacetic, lactic, propionic, and formic acids.
These acids destroy the microbial cells by penetrating their cell envelope and acidify the cell’s
interior. The efficiency of these sanitizers are dose dependent and have great potential on
surfaces where they may persist for long periods of time such as stainless steel (Marriott, 1994).
The major disadvantage to the use of acid sanitizers is that they are highly corrosive (Guthrie,
1992).
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Bacteriophages: Overview and Discovery
Bacteriophages have been used as a biological control method for various applications.
Bacteriophages are viruses which use bacteria as a host for undergoing replication. The
bacteriophages attach to specific bacterial cells and releases endolysins which degrade the
bacterial cell wall. This allows the bacteriophage DNA to enter the cell where it hijacks the
host’s metabolic machinery to produce phage particles. The particles then self assemble and
newly formed bacteriophages escape the host through cell lysis. These newly produced
bacteriophages can then repeat this process with additional bacterial host cells (Doyle 2007).
Bacteriophages can be divided into five groups: tailed bacteriophages, polyhedral DNA
bacteriophages, polyhedral RNA bacteriophages, filamentous bacteriophages, and pleomorphic
bacteriophages (Ackermann, 2005). Of these the tailed bacteriophages account for the majority
with ca. 4,950 different strains being identified (Ackermann, 2001). The tailed bacteriophages
are all within the order Caudoviridae and are divided into three families based on their tail
structure. These families include Myoviridae (contractile tail), Siphoviridae (long, noncontractile tail), and Podoviridae (short, non-contractile tail) (Ackermann, 2001).
The tailless bacteriophages only account for 4% of the identified bacterial viruses
(Ackermann, 2001). The first type of tailless bacteriophage is the polyhedral bacteriophages,
which contain an icosahedral head and have cubic symmetry (Ackermann, 1999). The polyhedral
bacteriophages include Microviridae (ssDNA), Corticoviridae (dsDNA), Tectiviridae (dsDNA),
Leviviridae (ssRNA), and Cystoviridae (dsRNA) (Ackermann, 2005). The second group of
tailless bacteriophages is the filamentous bacteriophages, which include the families Inoviridae
(ssDNA), Lipothrixviridae (dsDNA), and Rudiviridae (dsDNA) (Ackermann, 2005). The final
type of tailess bacteriophage is the pleomorphic bacteriophages, which includes the families
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Plasmoviridae (dsDNA) and Fuselloviridae (dsDNA) (Ackermann, 2005). Common
characteristics of the different bacteriophages are summarized in Table 1.10.
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Table 1.10 Characteristics of identified bacteriophage groups1
Shape
Tailed

Family
Myoviridae
Siphoviridae
Podoviridae
Polyhedral
Microviridae
Corticoviridae
Tectiviridae
Leviviridae
Cystoviridae
Filamentous
Inoviridae
Lipothrixviridae
Rudiviridae
Pleomorphic Plasmaviridae
Fusseloviridae

Nucleic
Acid
dsDNA
dsDNA
dsDNA
ssDNA
dsDNA
dsDNA
SSRNA
dsRNA
ssDNA
dsDNA
dsDNA
dsDNA
dsDNA

Adsorption Site
cell wall, capsule, pili, flagella
cell wall, capsule, pili, flagella
cell wall, capsule, pili, flagella
cell wall
cell wall
pili, cell wall
pili
pili, cell wall
pili
pili
cell wall
plasma membrane
?

1(Ackermann, 2005)
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Infection
by
DNA
DNA
DNA
DNA
?
DNA
RNA
capsid
virion
?
?
DNA
?

Host-Virus
Relationship
lytic or temperate
lytic or temperate
lytic or temperate
lytic
lytic
lytic
lytic
lytic
temperate
temperate
carrier state
temperate
temperate

Example Members
T4
1243
Lambda
3011
T7
696
ØX174
40
PM2
3
PRD1
18
MS2
39
Ø6
1
fd
57
TTV1
6
SIRV-1
2
L2
7
SSV1
7

The idea of using phage as a form of treatment has gained significant interest as
an alternative to antibiotics. The majority of antibiotics (50-70%) used in the United
States are given to farm animals as a prophylactic, to treat livestock, or as a growth
promoter (Gustafson, 1991). The overuse of these antibiotics may have contributed to the
decline in efficiency of the antibiotics in humans, but banning their use completely may
have a negative effect on the health of the animals they have been administered to (Kutter
and Sulakvelidze, 2005). An alternative method of treatment, such as bacteriophage
therapy, is necessary. The use of phage offers multiple advantages: the host specificity is
not likely to select for phage resistant bacterial strains, resistance against phage does not
affect the effectiveness of antibiotics given to humans, and phage mixtures can be easily
modified and rapidly developed against resistant bacteria (Kutter and Sulakvelidze,
2005).
The use of bacteriophage as a therapeutic agent was first realized by Felix
d’Herelle in 1919. D’Herelle was conducting research to determine if phage could be
used to prevent the natural infection of chickens by Bacillus gallinarum. The phage
appeared to prevent development of avian typhosis, the disease caused by B. gallinarum.
The treatment was then performed in large scale in rural areas of France where the
disease had developed into an epidemic. The flocks of chickens that received the phage
treatment “had fewer deaths, the duration of the epidemic was shorter, and second rounds
of infection were prevented” (d’Herelle, 1921; Kutter and Sulakvelidze, 2005).
D’Herelle also demonstrated that the administration of phage to water buffalo in
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Indochina could prevent infection with Pasteurella multocida, the causative agent of
bovine hemorrhagic septicemia (d’Herelle, 1926). The use of bacteriophages as a form
of therapy has been investigated well before the introduction of antibiotics. In the 1930s,
such therapy was being marketed by American pharmaceutical companies. During World
War II, the Germans and Soviets were using phage therapy to treat dysentery; however,
the advent of antibiotics in the 1940s caused a decline in the need for research with phage
therapy. Today with the prevalence of antibiotic resistant bacteria on the rise,
bacteriophage research is on the rise as well especially in terms of biopreservation of
food products. Bacteriophages naturally found in the food microbiota are safely
consumed as part of the human diet. It is possible then that bacteriophages can be used to
reduce or eliminate contamination by foodborne pathogens such as Salmonella (Doyle
2007).
Life Cycle of Bacteriophages
Bacteriophages have two alternative life cycles, lysogenic or lytic. In both cycles,
the virus will adhere to specific receptors on the bacterial cell’s surface, where it will
penetrate the surface and inject its nucleic acid into the host cell. Once the genetic
material is inside the cell, the bacteriophage will enter one of two life cycles. At this point
the bacteriophage may enter the lysogenic phase by inserting the nuleic acid into the
chromosome of the bacterial host. This state is referred to as a prophage. The prophage is
replicated along with host cell replication so that all progeny will contain the
bacteriophages genetic material as well. The bacteriophage will remain in this prophage
form until it is induced to leave the host chromosome, replicate, and lyse the cell. The
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second route for the bacteriophage is the lytic cycle, which is the focus of this study and
discussed in more detail in the following paragraphs (Cowan and Talaro, 2009).
Bacteriophage infection begins with the attachment of the bacteriophage virus to
the bacteria’s surface receptors. Attachment is initiated when the tail fibers or spikes of
the virus recognize and bind to specific surface receptors of its bacterial host. In gramnegative bacteria numerous components can serve as a surface receptor including any of
the outer membrane proteins, the lipopolysaccharides, and the oligosaccharides. While
some bacteriophages only require a single attachment type of receptor, others such as T4like phages go through a two-part attachment process involving two types of receptors. In
the case of the T4-like bacteriophages, at least three of the six tail fibers have to bind to
their surface receptors which trigger the rearrangement of the baseplate proteins in the
phage allowing the spike to irreversibly bind to the host’s surface (Guttman et al., 2005).
Following attachment, the bacteriophage penetrates the surface of the host cell
and injects its genetic material into the cell. The “injection” process actually involves a
series of mechanisms for the transfer of DNA that is specific for each bacteriophage. The
general process initiates when the tail pins release enzyme that allow them to break
through the cell wall and inner membrane. Once this opening has been made the
bacteriophage’s genetic material is released into the cell. The bacteriophage also has
mechanisms that prevent the genome from leaving the capsid prematurely. The process of
how the DNA enters into the host cell is poorly understood and is dependent on the
bacteriophage involved. For example, DNA enters the host cell from T7 phages as a
result of its transcription. Once inside the cell, the bacteriophage genome is susceptible to
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degradation by host cell enzymes, so bacteriophages have evolved mechanisms to protect
their genetic material. One way in which they do this is by circularizing their DNA
through the use of terminal redundancies (“sticky ends”). Some have incorporated an
irregular nucleotide that is not commonly found in DNA or RNA such as
hydroxymethyldeoxyuridine or hydroxymethyldeoxycytidine which are found in SP01
and T4 bacteriophages, respectively. As another mechanism, some phages such as the
Streptococci phage SD-1 and the coliphage N4 have evolved so they no longer contain
sites that are commonly recognized by enzymes of their natural host bacterial species
(Guttman et al., 2005).
Inside the host cells, the bacteriophage genome is recognized by the host RNA
polymerase leading to the initial transcription and translation of “early genes”. The
products of these genes are responsible for blocking host proteases and restriction
enzymes, terminate host cell metabolism, and denature host proteins. After this is
complete, a second set of “middle genes” is transcribed and translated to produce the
products needed for replication of the bacteriophage genome. Following replication, a
final set of “late genes” is transcribed and translated to produce the protein components
of the bacteriophage particles. In all of these processes, the bacteriophages either produce
sigma factors or DNA binding proteins to reprogram the host cell RNA polymerase or
they contain a gene set that is transcribed and translated early that codes for its own RNA
polymerase. Additional adaptations include the degradation of the host DNA and
preventing protein synthesis (Guttman et al., 2005).
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Following replication and the production of components of the bacteriophage
particles, the bacteriophages have to be assembled and the genetic material needs to be
packaged within the capsid head. The packaging of the capsid protein involves
interactions between scaffolding proteins and structural proteins. At one vertex of the
icosahedral head there is a portal complex which is the origin site for head assembly,
docking site for packaging enzymes, and the site at which the genome enters the capsid.
At some point during the packaging process, the head expands in order to accommodate
the bacteriophage DNA or RNA (Guttman et al., 2005).
Once the bacteriophages have completely assembled, they must exit the cell
through lysis. The process of lysis is dependent on the bacteriophage type and its timing
is crucial (Guttman et al., 2005). If the cell is lysed too soon, there is not enough
bacteriophages to continue the lytic cycle, but prolonging lysis too long results in the loss
of opportunities for infection (Abedon, 1990). Tailed phages use a two enzyme system
for lysis. They produce pores in the inner cytoplasmic membrane by an enzyme. The
second enzyme, lysin, passes through the pores formed by holin and begins breaking
down the bonds between the layers of peptidoglycan. The tail-less phages produce
individual enzymes that inhibit the host cell enzymes responsible for peptidoglycan
formation (Guttman et al., 2005). The lytic process is illustrated in Figure 1.2
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Figure 1.2 Bacteriophage lytic cycle (Cowan and Talero, 2009)
Bacteriophage Treatment of Raw Meats and Surfaces
While there is a lack of studies investigating phage usage as a treatment method in
animal by-products, several researchers have demonstrated the possibility of creating
bacteriophage mixtures capable of reducing Salmonella levels significantly in the raw
animal meats. One group of researchers found that phage treatment can significantly
reduce S. Enteritidis (SE) levels in poultry products (Higgens et al., 2005). The study
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found that the phage PHL4 (108 and 1010 PFU/ml) was capable of reducing SE on the
carcass by 85-93% and in the rinse water by 50-100%. In addition, a 72 phage cocktail
(107-108 PFU/ml) used to treat SE on commercially processed turkey carcasses resulted
in a 50-60% reduction in SE. Another study demonstrated that SE (106 CFU/ml)
contamination on chicken skin was significantly reduced by washing the skin with 109
PFU/ml of three wild-type bacteriophage cocktail (Fiorentin et al., 2005). During storage
at 5°C, a significant difference between the means of Salmonella populations on the
control and experimental skin was observed on days 3, 6, and 9 with Salmonella
reduction at 2.27, 4.56, and 4.49 x 108 (CFU / cut), respectively.
Studies have shown bacteriophages to be effective against Salmonella serovars
other than Enteritidis as well. Atterbury et al. (2007) recovered 232 phages from poultry
farms, abattoirs, and wastewater from 2004-2005. Among those collected phages, the
three with the broadest range against Enteritidis, Hadar, and Typhimurium were selected
for further study. The phage cocktail resulted in ≥ 4.2 and ≥2.19 log10 CFU reduction in
Enteritidis and Typhimurium cecal colonization, respectively (Atterbury et al., 2007).
There are also studies demonstrating the ability of bacteriophage to reduce the
population of bacterial cells attached to an inert surface. Roy et al. (1993) studied the
effectiveness of phage treatment against L. monocytogenes. In their study, a three phage
mixture (H387, H387-A, and 2671) was used to treat stainless steel templates that had
been contaminated with the pathogen. Phage treatment resulted in a 3 log decrease in L.
monocytogenes populations. The elimination of L. monocytogenes from stainless steel
was also investigated by Hibma et al. (1997).
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Bacteriophage Treatment of Biofilms
Often bacteria are not simply attached to environmental surfaces but are rather
components of a large microbial network known as a biofilm. A biofilm can be composed
of one or various species of bacteria and their excreted products. The concern for phage
treatment is to ensure that the phage can actually come in direct contact with the bacterial
cells within the biofilm matrix. It has been shown that many biofilms actually contain
water filled pathways that can transport the phage into the biofilm’s interior and provide
access to the bacteria cells. In addition, a large number of phages are capable of
producing polysaccharases or polysaccharide lyases. These enzymes are host specific so
they are only effective against a range of related polysaccharide structures. Phages
capable of degrading the exopolysaccharide (EPS) of various gram-negative bacteria,
including species that are capable of producing a biofilm, have been isolated (Sutherland,
2004).
Studies on the effect of phage on biofilm produced by Enterobacter agglomerans
revealed that the biofilm can be degraded if two conditions were met (Hughes, 1998a;
Hughes, 1998b). First the bacterium being investigated has to be susceptible to the phage
being used. Second the polysaccharide lyases produced by the phage has to be able to
degrade the biofilm’s EPS. Even when only one of these conditions were met, the phage
still cause a significant amount of biofilm degradation.
The effects of phage treatment on single species biofilms have been well
documented. Doolittle et al. (1996a) discovered that the matrix produced by an E. coli
biofilm was ineffective in preventing phage T4 from infecting the bacterial cells. To
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confirm their findings, the T4 phage was labeled with fluorescent and chromagenic
probes and introduced to the E. coli biofilm. Microscopic observations revealed that the
T4 was infecting the E. coli cells and were not inhibited by any of the extracellular
components within the biofilm (Doolittle et al., 1996b). Karunasagar et al. (2007)
demonstrated that phage can be used to reduce Vibrio harveyi levels in biofilm formed on
high density polyethylene. When using a phage concentration of 105 PFU/ml, V. harveyi
counts were reduced nearly 1 log CFU/cm2 after 18 h. A higher phage concentration (108
PFU/ml) reduced the V. harveyi counts by 1 log every 6 h from 2.19 x 106 to 9.40 x 103
CFU/cm2 in 18 h. Another study determined the effectiveness of phage KH1 against E.
coli O157:H7 biofilm (Sharma et al., 2005). The phage was able to significantly reduce
(P<0.05) bacterial counts in biofilms produced from strain FRIK 816-3 from an initial
concentration of 4.0 log CFU per coupon to 2.8 log CFU per coupon and 2.7 log CFU
per coupon after 24 and 48 h of phage treatment, respectively.
Research on the use of phage for biofilms composed of multiple bacterial species
has not been thoroughly investigated, and some reported less promising results
(Sutherland 2004). Storey and Ashbolt (2001) attempted to treat biofilm composed of
Bacteroides fragilis and E. coli in an urban water distribution system with phages. The
phages were initially taken in by the biofilm that had formed on stainless steel and
polythene surfaces; however, following the initial treatment, phage numbers began to
decrease rapidly, suggesting that the phages were not infecting the host cells. Their study
has shown that biofilms composed of multiple bacterial species may contain additional
barriers such as bacterial cell co-aggregation (Rickard et al., 2003) that phage treatment
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must overcome to be successful. Therefore, additional research into developing phage
treatments against biofilms composed of more than one species of bacteria is needed.
Examples of Salmonella Reduction via Bacteriophage Treatment
Several studies have demonstrated that phage treatment can be very effective
against Salmonella contamination. For example, a study conducted by Modi et al. (2001)
investigated whether the addition of phage SJ2 to the starter culture used in cheddar
cheese production would reduce the survival of Salmonella. A strain of Salmonella
Enteritidis that had been associated with an outbreak due to contaminated cheese was
inoculated into the milk post pasteurization at 104 CFU/ml. The results showed that the
experimental cheese made with pasteurized milk was negative for Salmonella
contamination after 88 days. The experimental cheese produced with raw milk treated
with bacteriophage had very low Salmonella contamination levels of 50 CFU/g. In
contrast, all cheeses produced without bacteriophage had Salmonella counts of 103
CFU/g after 99 days. Whichard et al. (2003) demonstrated that both the wild-type and a
large plaque variant of the Felix 01 phage can be used to control S. Typhimurium
contamination on chicken frankfurters. The results indicated both phage strains were
capable of reducing S. Typhimurium levels by 102 CFU/g. A study by Leverentz et al.
(2001) demonstrated the potential use of phages for reducing Salmonella contamination
on fresh produce. Their results demonstrated that the phage was capable of reducing
Salmonella levels on fresh cut honey-dew melon by 3.5 logs at 5°C and 10°C, and a 2.5
log reduction at 20°C. There was no significant reduction of Salmonella on apple slices at
any temperature. Titers of the phage were stable on the honey-dew melon but were non-
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detectable on the apples after 48h, this is possibly due to the more acidic pH (4.2) of the
apples as opposed to that of the melon (5.8). Pao et al. (2004) studied the effect of two
different phages simultaneously against three serotypes of Salmonella. One phage was
effective against S. Typhimurium and S. Enteritidis. The other phage was effective
against S. Montevideo. Phage treatment was shown to significantly suppress growth of S.
Typhimurium and S. Enteritidis in both broccoli and mustard seeds for 24 h. A
combination of the two bacteriophages suppressed the growth of the three serotypes by
0.57 ± 0.04 log (P<0.001) in the broccoli seeds. One desirable aspect of phage treatment
is the host specificity of bacteriophages. In terms of Salmonella treatment, this host
specificity is a hurdle for reducing contamination levels. There is not a single phage
capable of lysing all known serovars of Salmonella. In fact, a particular phage may not
even be capable of lysing all members of a particular serovar. To overcome this
shortcoming, a “cocktail” of phages must be designed capable of lysing all Salmonella
strains of interest (Joerger 2003). The production of an effective phage cocktail for
Salmonella has been reported previously. For example, Chighladze et al.(2001) reported
to have developed a phage cocktail capable of lysing 232 of 245 Salmonella isolates
composed of 21 serovars with 78 pulse field gel electrophoresis (PFGE) pattern types
(Joerger 2003).
Bacteriophage Therapy in Animals
As previously mentioned, the use of bacteriophages as a therapeutic agent dates
back 1919 with the work of Felix d’Herelle (Sulakvelidze and Barrow, 2005).
Salmonellosis in mice served as one of the earliest models for bacteriophage therapy. For
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example, Topley et al. (1925) tested the effectiveness of bacteriophage therapy in mice
infected with S. Typhimurium. The results indicated that the therapy did not reduce the
mortality rate or shedding of the bacteria in the feces. The ineffectiveness during this
study was contributed to the lack of optimization of the bacteriophage. The bacteriophage
used was found not to completely lyse the bacterial strain (Topley and Wilson, 1925).
Fisk’s study (1938) concluded that Salmonella infection could be prevented through the
use of bacteriophage therapy.
The interest in bacteriophage as a therapeutic agent was renewed by the work of
Smith and Huggins (1982). Their initial studies investigated the effectiveness of
bacteriophages specific to the K1 capsule antigen found on E. coli O18:K1:H7 ColV.
Their results indicated that a single injection of the bacteriophage (3 x 108) was more
effective than several antibiotics in protecting mice against infection by that E. coli strain.
In a subsequent study, Smith and Huggins (1983) tested the ability of a bacteriophage to
prevent infection in calves, piglets, and lamb by E. coli O9:K30.99. The mortality rates
for calves, piglets, and lambs infected with E. coli and left untreated were 100, 57, and
25%, respectively; whereas, the mortality rate for those animals treated with the
bacteriophage was 17, 0, and 0%, respectively.
The success of the in vivo studies by Smith and Huggins renewed the interest in
bacteriophage therapy. More recently, Huff et al. (2002) conducted three experiments to
determine the effect of bacteriophages on respiratory infections by E. coli in broiler
chickens. During all three trials, E.coli was administered by air-sac inoculation while the
bacteriophage was administered by either air-sac inoculation or in the drinking water.
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The results showed that bacteriophage treatment by air-sac inoculation reduced the
mortality rate from 80% to 0% or 30% depending on the concentration of bacteriophage
used. Treatment with the bacteriophage in the drinking water demonstrated the
bacteriophage was only effective when given prior to infection. When given prior to
infection, the bacteriophage was able to reduce the mortality rate from 85% to 0% or 35%
depending on the concentration of the bacteriophage. Biswas et al. (2002) demonstrated
that other bacteria, such as VRE, can be treated with bacteriophage therapy as well. The
bacteriophage was shown to prevent bacteremia caused by VRE infections in mice.
Recent studies have also tested the effectiveness of bacteriophage as a therapeutic
agent against Salmonella as well. Berchieri et al. (1991) were able to isolate several
phages with activity against S. Typhimurium. The isolated phages were then orally
administered to chickens infected with S. Typhimurium. The addition of the
bacteriophages was shown to significantly reduce the mortality rate. Phage 2.2 was one
of the most effective isolates during their study. It decreased the viable numbers of the
pathogen within the host’s alimentary tract. The Salmonella population was decreased by
1 log in the crop, intestine, and caeca of the chickens within 12 h of phage administration.
Salmonella counts in the liver were reduced by 0.9 log within 24 h of phage
administration. The results also demonstrated that administering the bacteriophage close
to the time of infection was significantly more efficient than delaying bacteriophage
administration. This was believed to be due to the nature of Salmonella which is an
intracellular pathogen. In theory, it is more effective to expose the Salmonella to the
bacteriophage before it is able to enter the epithelial cells in the intestinal tract. This study
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demonstrated that oral administration of bacteriophage to animals can reduce Salmonella
contamination levels.
Advantages of Bacteriophage Treatment/Therapy
The use of antibiotics as feed additives has become a major concern for national
health organizations and the livestock industry due to the increase in antibiotic resistant
pathogens in human health that have been linked to those antibiotics used in livestock
feed (Smith et al., 2002). This has led to the banning of many traditional antibiotics as
feed additives. For example, the European Union has banned the use of virginiamycin,
bacitracin zinc, spiromycin, and tylosin phosphate (Ferber, 2003). While the bans may
have decreased the amount of antibiotic use, it also poses health concerns to the livestock
which will lead to safety concerns in food products. An alternative treatment that is both
effective and safe to the animal host and environment is needed to replace the antibiotics
in the feed.
Bacteriophages may be the most environmentally safe alternatives available
considering they are naturally found in the environment and animal hosts. In addition,
they have several advantages over antibiotics. Typically the antibiotics used as feed
additives are broad spectrum so as to target as many bacterial species as possible. The
issue is when resistance arises it can occur in several different bacterial species.
Bacteriophages have a high specificity for their host, typically only infecting one
bacterial species or even a few serotypes within a species. An advantage with the use of
bacteriophages is that if there is bacteriophages resistance it would only arise in the
bacterial species that is their host and would have little to no effect on other species in the
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environment. The resistance mechanism for bacteriophages is not related to the
mechanisms developed in antibiotic resistance, so resistance to a bacteriophage will not
influence the efficiency of antibiotics that are used for pathogen treatment. When
resistance does occur, bacteriophages can be rapidly modified through natural selection to
produce a new treatment; whereas, antibiotics may require several years of research and
development to produce (Pirisi, 2000). In application, it has been demonstrated that
bacteriophages may be transferred between animal hosts. This transfer provides a large
advantage as a prophylactic due to the fact one animal could be administered the
bacteriophage and it would transmit throughout the population on its own (Smith et al.,
1987). A final advantage is that they are self-replicating, so a single dose would last
throughout the course of infection. This advantage would also mean a relatively low
initial dose could be used (Barrow and Soothill, 1997).
Summary
It is well established that finished rendered by-products can be contaminated with
pathogenic bacteria including Salmonella spp. and Enterococcus spp. The reason behind
this contamination is debatable and is one of the focuses of our study. Although the
material may be contaminated, the rendering process is still the best alternative available
for handling animal by-products, and it provides a valuable source of nutrients needed for
the finished animal feed. Although the benefits of the feed may outweigh the biological
risks, there is still concern that the feed serves as a continuous vehicle for introducing
pathogenic bacteria into the food chain. In this particular study, the focus is on
enterococci and Salmonella. Enterococci typically only cause mild treatable disease, so
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the concern is with VRE which has the capability of transferring the vancomycin
resistance genes to more pathogenic bacteria via conjugation.
Salmonella is one of the leading causes of human food-borne illness; therefore, its
presence in finished meals is of major concern. The heat used during the rendering
process is sufficient to kill pathogenic bacteria, which leads to the theory that the
contamination was resulting from cross-contamination within the rendering facility.
There are several potential sources for cross contamination including the incoming raw
material and the environmental surfaces found within the facility.
Due the potential for cross-contamination, it is important to develop a method for
reducing bacterial levels that is biologically safe and cost efficient. Bacteriophages could
potentially serve this need to the fact that they are self-producing and only affect their
determined bacterial host. Numerous studies have demonstrated the ability of
bacteriophages as a treatment method for both raw meat and hard surfaces such as steel.
Bacteriophages have also been show to be an effective means of preventing or reducing
infection within an animal host.
The objectives of this study were as follows:
•

Determining contamination levels of Salmonella spp. and Enterococcus spp.
within the finished rendered products provided by U.S. rendering facilities.

•

Characterizing and determining heat resistance of Salmonella and Enterococcus
isolated from the animal by-products.

•

Screening enterococci isolates for VRE and determining the level of resistance.
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•

Developing a bacteriophage cocktail capable of lysing Salmonella that had been
recovered from finished by-products

•

Using the produced bacteriophage cocktail to reduce Salmonella levels on
environemental surfaces (steel, rubber, HDPE plastic, and concrete) in the form of
attached cells and within a biofilm.

•

Using the bacteriophage cocktail to reduce Salmonella levels in the raw material
used to produce the rendered by-products.

•

Conducting an animal study to use the bacteriophage cocktail as a feed additive
for therapeutic purposes against Salmonella infection in mice.
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ANALYSIS OF SALMONELLA AND ENTEROCOCCI ISOLATED FROM
RENDERED ANIMAL PRODUCTS

Abstract
The objectives of this study were to determine the current status of bacterial
contamination in rendered animal products and analyze Salmonella and enterococci
isolates from the samples. One hundred and fifty samples were provided by various
rendering companies across the U.S., including the following meal types: feather, meat,
meat and bone, meat and bone from poultry, poultry, and blood meals. The average pH of
the meals ranged from 6.16 to 7.36, and the moisture content ranged from 1.9 to 11.5%.
The total bacterial counts were in the range of 1.7 to 6.68 log CFU/g with the highest in
blood meal and the lowest in meat meal. Enterococcus species were detected in 81.3% of
the samples and accounted for up to 54% of the total bacterial counts in some samples.
Both blood meal and feather meal were more contaminated (P < 0.05) with enterococci
than other meal types, although all blood meals were from a single company. Salmonella
was detected in 8.7% of the samples. E. coli was not detected in any of the samples, but
coliforms were detected in four samples. Among enterococci isolates, three were
vancomycin resistant. Thirteen serotypes of Salmonella displayed 16 pulse field gel
electrophoresis (PFGE) patterns. PFGE analysis has indicated that Salmonella
contamination was not persistent in the plant environment over time. D-values for the
Salmonella isolates at 55°C, 60°C, and 65°C were in the ranges of 9.27-9.99, 2.07-2.28,
and 0.35-0.40 min, respectively. These results suggest that the presence of Salmonella in
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the finished products may be due to post-processing contamination. This study has also
revealed that the rendering industry has microbiologically improved their products as
compared to earlier studies.
Introduction
Each year, the U.S. meat industry generates over 2.3 x 1013 kg of animal parts not
typically included in the food supply such as fat and bone trimmings, meat scraps, blood,
offal, and feathers (Franco and Swanson 1996). Annually, the U.S. produces ca. 11.2
billion pounds of protein and 10.9 billion pounds of fats. Approximately 85% of these
products, are then used in the production of animal feed ingredients (Meeker and
Hamilton, 2006). A large portion of these U.S. products are then exported. In 2005, the
amount of exported finished products worldwide was ca. 1.7 million metric tons with 0.8
million metric tons being exported by the U.S. (Swisher, 2006). These by-products are
often contaminated with high numbers of microorganisms and will spoil rapidly
becoming a public health hazard if left untreated. Meat, meat and bone, feather, poultry
and blood meals are produced by the rendering industry from these by-products of meat
processing plants. Therefore, the rendering industry has played a significant role in
recycling inedible parts of food animals into a variety of value-added products (Franco
and Swanson 1996). Most importantly, the rendering industry contributes to maintaining
a healthy environment by using processing conditions capable of eliminating pathogenic
microorganisms including bacteria and viruses.
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While adding rendered animal meals to feed provides many needed nutrients and
minerals essential for animal growth, animal feed is a source of foodborne pathogens
contributing to human foodborne illnesses (Crump et al. 2002). Although the rendering
process involves high levels of heat treatment, there is still potential for the finished meal
to become contaminated with bacteria. When these contaminated products are used as
ingredients of animal feed, inoculation of other animals in the food chain can occur and
lead to potential human exposure. A previous study on rendered products revealed
poultry meal containing bacterial populations ranging from 1.6 to 4.02 log CFU/g
(Hofacre et al. 2001). About 85% of the poultry and meat and bone meal samples
contained bacteria resistant to amoxicillin, ampicillin, clavulanic acid and cephalothin.
Some of the most commonly isolated bacteria were Acinetobacter colcoaceticus,
Citrobacter freundii, and Enterobacter cloacae. Salmonella was also isolated from 14%
of the meat and bone samples (Hofacre et al. 2001).
Enterococci have often been used as probiotics in food production, but also
account for 12% of the nosocomial infections in the U.S. causing bacteremia,
endocartitis, and infections, with Enterococcus faecalis and Enterococcus faecium
causing the majority of these infections (Franz et al. 2003). Enterococci are resistant to
various stresses including mild heat treatment and are intrinsically resistant to a wide
variety of antibiotics. More specifically, resistance to vancomycin is of major concern
since vancomycin is considered to be the last resort for enterococci treatment (Manero et
al. 2006, Wegener 2003). Therefore, it is important to identify potential reservoirs for
enterococci in an effort to control the possible contamination with this microorganism.
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The purpose of this study is two-fold. First it is necessary to determine if the
rendered meals may serve as a vehicle for bacteria, specifically Enterococcus spp. and
Salmonella spp. Although early studies have demonstrated that rendered products are
frequently contaminated with bacteria including Enterococcus spp. and Salmonella spp.,
the technological improvements of the rendering process have been made, and an updated
study is needed to assess the microbiological quality of these products by taking rendered
products directly from the production line to reduce the potential for post-processing
contamination. The study then determined whether the contamination is likely to be a
result of insufficient sterilization methods or through post-processing contamination.
Materials and Methods
Analysis of moisture content, pH, and water activity. To determine the
moisture content, approximately 1g of each sample was weighed and dried in a
mechanical convection oven (Blue M Electric Co., Blue Island, IL.) at 105°C for 24 h.
For pH testing, one gram of each sample was mixed with 50 ml of distilled water and
analyzed using a pH meter (Orion perpHect Log R meter model 310, Boston, MA.). The
water activity (aw) values were determined using a Rotronic-Hygroskop DT (Rotronic
Instrument Corp., Huntington, NY.).
Bacterial enumeration. One hundred and fifty different rendered samples were
provided by twelve rendering companies throughout the U.S from August, 2004 to
February, 2005. The products were separated into six meal types: feather meal (n=30),
meat meal (n=14), meat and bone meal (MBM) (n=37), meat and bone meal from poultry
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(MBM-P) (n=6), poultry meal (n=51), and blood meal (n=12). Samples were stored at
4°C prior to analysis.
Samples in duplicate were serially diluted using 0.1% sterile peptone water.
Aliquots of each dilution were spread-plated onto Tryptic Soy Agar (TSA, BectonDickinson and company, Sparks, MD.) for total bacterial counts (TBC) and Bile Esculin
Agar (BEA, Becton-Dickinson and company) for enterococci counts, separately. Plates
were incubated at 37°C for 24 h. Bacterial counts were reported as CFU/g, and the
detection limit for both TBC and enterococci was 100 CFU/g.
Detection of E. coli/coliforms and Salmonella. Ten grams of each sample in
duplicate were mixed with 90 ml of universal pre-enrichment broth (UPB, BectonDickinson and company) and incubated at 37°C for 24 h. For E. coli/coliforms testing, 1
ml of each enriched sample was placed on a Petrifilm™ E.coli/coliforms count plate (3M
Microbiology Products, St. Paul, MN.) and incubated at 37°C for 48 h. For Salmonella
detection, the enriched sample was inoculated into Tetrathionate Broth (TTB, BectonDickinson and company) and incubated at 37°C for 24 h, followed by plating onto xylose
lysine tergitol-4 (XLT-4, Becton-Dickinson and company). Presumptive Salmonella
isolates were then confirmed with a Salmonella identification latex test (Oxoid®,
Basingstoke, Hants, UK). The above procedure deviated some from FDA
recommendations due to the quantity of samples received. Standard procedures require a
25 g sample, but some samples were not large enough to do so.
Bacterial isolation. Purified isolates from both BEA (Enterococcus, n=200) and
XLT-4 (Salmonella, n=30) plates were streaked onto TSA, preserved in TSB containing
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20% glycerol, and stored at -80°C. These isolates were used for further testing including
antibiotic and heat resistance determination.
Enterococci spp. confirmation. The prospective enterococci isolates were gramstained and then tested for growth at 45°C in TSB, growth in TSB containing 6.5% NaCl,
catalase activity, and pyrrolidonyl arylamidase activity using PYR disks (Remel, Lenexa,
KS.). All isolates that tested positive as an Enterococcus spp. were screened for
vancomycin resistance by plating onto BEA supplemented with 6 µg/ml of vancomycin
(Sigma-Aldrich, St. Louis, MO.) and incubating at 37°C for up to 48 h.
Determination of minimum inhibitory concentration (MIC) of vancomycin.
The agar dilution assay was used as described by CLSI protocol (CLSI, 1997) using
Mueller Hinton agar (MHA, Becton-Dickinson and company). Plates were prepared
using the following concentrations of vancomycin: 4, 8, 16, 32, 64, and 128µg/ml.
Enterococci isolates were inoculated onto the MHA plates using a replica plater device
(Sigma). Plates were incubated at 37°C for up to 48 h.
PCR identification of genus and species for potential vancomycin resistance
enterococci (VRE) isolates: The DNA of potential VRE isolates (n=16) were extracted
by boiling method and used for genus confirmation and identifaction of the species E.
faecium and E. faecalis. The primers, reaction mixtures, and reaction protocol were
performed according to Shank et al. (2008), Sedgley et al. (2005), and Jackson et al.
(2005), respectively. The PCR reaction was conducted in a Bio-RadiCycler iQTm (BioRad Laboratories, Hercules, CA), and the resulting products underwent electrophoresis in
a 1.5% agarose gel at 70 v, and stained in ethidium bromide. Images of the gels were
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captured using a GelDoc 2000 (Bio-Rad Laboratories). E. faecalis ATCC 29212, E.
faecium ATCC 51229, and E. coli G5244 were used as controls.
Detection of vanA and vanB genes through PCR analysis. The DNA of
potential VRE isolates (n=16) were extracted by boiling method and used to detect the
presence of the vanA or vanB genes. The primers, reaction mixtures, and reaction
protocol were performed according to Dutka-Malen et al. (1995). The PCR reaction was
conducted in a Bio-RadiCycler iQTm (Bio-Rad Laboratories, Hercules, CA), and the
resulting products underwent electrophoresis in a 1.5% agarose gel at 70 v, and stained in
ethidium bromide. Images of the gels were captured using a GelDoc 2000 (Bio-Rad
Laboratories). E. faecium ATCC 51559 (vanA), E. faecium ATCC 51229 (vanB) and E.
coli G5244 were used as controls.
Thermal resistance screening. Bacterial isolates (Salmonella, enterococci, and
VRE) were screened for thermal resistance. All cultures were grown on TSA at 37°C for
24 h, and each culture was resuspended in saline and inoculated into TSB at a final
concentration of 5 x 106 CFU/ml. The inoculated TSB tubes were incubated at 60° and
70°C in a Haake V26 circulating water bath (Thermo Haake GmbH, Karlsruhe,
Germany) for Salmonella and enterococci, respectively. Three tubes were removed
simultaneously at pre-determined time intervals and placed immediately into an ice bath.
After the tubes had cooled, each tube was incubated at 37°C for 24 h and observed for the
presence of growth.
D-value and z-value determination. The six most heat resistant Salmonella
isolates were inoculated into TSB and incubated at 37°C for 24 h. After incubation, all
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samples were diluted in saline and inoculated into TSB at a final concentration of ca. 5 x
106 CFU/ml. The inoculated tubes were then incubated separately at 55° (n=6), 60°
(n=10), and 65°C (n=10) in a circulating water bath. The internal temperature of the broth
was monitored by J-type thermocouples (DCC Corporation, Pennsauken, NJ) attached to
a Hotmux data logger (DCC Corporation) and tubes were removed at pre-determined
time intervals. After cooling in an ice bath, the inoculated tubes were then spiral plated
onto TSA with a Autoplate 4000 (Spiral Biotech Norwood, MA) and incubated at 37°C
for 24 h. The log CFU/ml values were plotted against heating time to determine the line
of best fit. The formula for D-value calculation was D= t / (log No – log Nf), where t is
total time, No is the intitial bacterial concentration, Nf is the final bacterial concentration,
and D is the D-value. D-values were determined for each isolate at the three tested
temperatures. Z-values were determined by plotting log D-values (y-axis) vs. heating
temperatures (x-axis). The z-value is the temperature change required to change the Dvalue by 1 log.
Serotyping and PFGE analysis of Salmonella isolates. Twenty-nine Salmonella
isolates were serotyped by the FDA lab using the Kauffman-White Classification system,
and the PFGE patterns of these isolates were analyzed following PulseNet’s standard
PFGE protocol for Salmonella (Ribot 2006). Briefly, plugs were prepared by mixing
SeaKem Gold agarose and 1% sodium dodecyl sulfate (SDS) with Salmonella (108
CFU/ml) and proteinase K. Once cell lysis was complete, the plugs underwent restriction
digestion by XbaI. The plugs were then washed, cast into an agarose gel, and underwent
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electrophoresis using a CHEF Pulse-Field system (Bio-rad). The gel was stained with
ethidium bromide and imaged using a Gel Doc system (Bio-Rad).
Statistical analysis. All plate count data were converted into log10 values. The
mean counts and standard deviations were determined for the samples according to meal
type as well as by the commercial renderer. The data were subjected to analysis of
variance with a test criterion (F statistic) and type I error controlled at P = 0.05. The
Tukey’s multiple comparison procedure of the Statistical Analysis System (SAS 2001,
Cary, NC.) was used to compare all pairs of means when the test criterion for the analysis
of variance was significant.
Results
In this study, 150 fresh samples of feather, meat, MBM, MBM-P, and blood
meals were analyzed. Feather, meat, MBM, and poultry meals were provided by at least 4
companies whereas blood and MBM-P were produced by a single company.
The average pH of the meal types ranged from 6.16 to 7.36 (Table 2.1). The pH
of blood meal was higher (P < 0.05) than those of all other meal types. Feather meal
contained the highest amount of moisture (5.99%); whereas, meat meal contained the
lowest amount of moisture (2.5%) (Table 2.1). Both feather and blood meals were higher
(P < 0.05) in moisture content than meat and MBM meal. The water activity of different
types of meal was analyzed; however, the aw values in the range of 0.41 to 0.49 were
consistent among the meal types (data not shown).
Total bacterial counts (TBCs) ranged from 1.70 to 6.68 log CFU/g, and
enterococci counts ranged from less than 1.40 to 5.70 log CFU/g. The mean TBCs for
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each meal type ranged from 3.70 to 5.88 log CFU/g; whereas, mean enterococci counts
were in the range of 1.60 to 3.85 log CFU/g (Figure 2.1). Total bacterial counts were
found to be the highest in blood meal and the lowest in meat meal. Enterococci counts
were also the highest in blood meal but the lowest in the MBM-P. Blood meal was more
contaminated (P < 0.05) with total bacteria than other meal types, and both blood and
feather meals contained higher levels (P < 0.05) of enterococci.
Comparisons between meal type and company for TBCs and enterococci counts
are presented in Tables 2.2 & 2.3, respectively. Since 38 out of 150 samples were
received without the company information, those samples were excluded in both Tables.
There were differences (P < 0.05) in TBCs for feather, meat, MBM, and poultry meal
types among companies. The feather and poultry meal produced by company F were
contaminated with the highest (P<0.05) levels of total bacteria for that meal type. There
were also differences (P < 0.05) in enterococci counts in MBM and poultry meal among
companies. All meals (feather, meat, or poultry) produced by company A and F had the
highest levels (P < 0.05) of enterococci contamination. For company H, blood meals
contained higher TBC and higher enterococi counts than the other four meal types they
produce. Enterococcus spp. was detected in 122 of 150 samples (81.3%), and accounted
for up to 54% of the total bacterial counts in some samples (Table 2.4). Over 90% of the
blood or feather meals were positive for enterococci.
E. coli was not detected in any of the samples tested, but coliforms were detected
in a few samples (4 out of 150) of the feather, MBM, and poultry meals (Table 2.4).
Salmonella was detected in 13 of the 150 samples (8.7%) including feather, meat, MBM,
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and poultry meals. In general, the poultry meal samples had the highest contamination
rate (13.7%) for Salmonella (Table 2.4).
Approximately 76% of the 200 isolates collected were confirmed enterococcus by
traditional confirmational tests. Vancomycin resistance screening revelaed that of the 152
enterococcus isolates only 16 (10.5%) are potentially resistant. These 16 isolates were
confirmed as enterococcus by PCR assay. PCR analysis also indicated none of the 16
isolates were E. faecalis or E. faecium (data not shown). The results of the agar dilution
test revealed that the MIC of 13 enterococci isolates was 16 µg/ml or less; whereas, only
three isolate were able to grow at 32 µg/ml. Since the breakpoint for VRE is 32 µg/ml,
three (2%) enterococci isolates were considered VRE in this study (Willey 1992). PCR
analysis of the 16 isolates further revealed that none of the isolates contained the vanA or
vanB that are traditionally associated with higher levels of vancomycin resistance.
After initial thermal resistance screening, six Salmonella isolates were tested
further for D- and z-vlaue determinations. Of those six isolates, five were isolated from
the rendered products consisting of different serotypes as well as an additional isolate
provided by SC DHEC from a SC boiled peanut outbreak were used to determine D- and
z-values (Table 2.5). There was no difference (P < 0.05) between all determined D-values
at each temperature with a maximum range of 0.85 minutes between them. All z-values
were approximately 7°C.
A total 13 distinguishable serotypes including Senftenberg, Oranienburg, Idikan,
Johannesburg, IIIa. 42: z4,z23, Banana, Demerara, Putten, Molade, Montevideo,
Mbandaka, Livingstone, and Amsterdam were identified. PFGE analysis was able to
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further classify all distinguishable serotypes except those that were S. Banana. There
were 16 PFGE patterns for 12 serotypes, including three types of S. Senftenberg, two
types of S. Mbandaka, and two types of S. Demarara.
Discussion
To ensure the microbiological safety of rendering end products, rendering
companies use various forms of heat treatment depending on the meal type. Three forms
of heat treatment were analyzed in this study. The first method of treatment is for meat,
MBM, MBM-P and poultry meal. This process uses a continuous rendering process,
which heats the raw material in a horizontal, steam-jacketed cylindrical vessel to a final
temperature ranging from 121 to 135°C (Franco and Swanson 1996). After the fat is
removed, the meal is dried and packaged (National 2005). In the continuous process of
blood meal, the whole blood is passed through a system of tubes where steam is injected
to coagulate blood solids. After separation, the blood solids are fed into a gas-fired
drying system, direct-contact ring dryer, a steam tube, or rotary dryer (Franco and
Swanson 1996). As for feather meal production, the keratin of poultry feathers is first
converted into short chain amino acids by chemical hydrolysis in a batch cooker at
temperatures ranging from 138 to 149oC under pressure. The feather meal is then dried
in a manner similar to the way blood meal is (McGovern 2000). In this study, total
bacterial and enterococci counts based on meal type from the highest to lowest were:
blood meal > feather meal > meat meal. This would suggest that the continuous
rendering system for meat, MBM, and poultry meal is more effective than the methods
used for feather and blood meal in eliminating bacteria. Although blood meal samples
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were from a single company (H), both total bacterial and enterococci counts in blood
meal were higher (P<0.05) than those in MBM, poultry, and meat meal produced by this
company. In addition, the microbial contamination levels of raw materials can also affect
the bacterial levels and contents in the finished meal products. A 2001 study indicated
that raw material used for rendered by-product production contains the following levels
of pathogens: Salmonella spp. 84.5%, Clostridium perfringens 71.4%, Listeria
monocytogenes 8.3%, Listeria spp. 76.2%, Campylobacter jejuni 20.0%, and
Campylobacter spp. 29.8% (Troutt et al. 2001).
Moisture is one of the key control points for preventing microbial growth of the
rendered product. In both blood and feather meal processing, the moist meals with ca. 50
to 55% moisture are subjected to drying If these meals are not properly dried, the
moisture content will remain high and microbial levels may increase as evidenced in our
study for both blood and feather meals. Although the moisture levels in animal meals
analyzed in this study were much lower than the minimal moisture level for bacteria
growth, some bacteria esp. Salmonella, if present, may persist for extended period of time
during storage (Doyle et al., 2001;Meat 1997).
The machinery, plant environment and workers can all serve as possible sources
of contamination as well. It is possible for bacteria to form biofilm on the machinery,
conveying belts, containers, and floor of the processing plant. Foodborne pathogens such
as E. coli O157:H7, Listeria monocytogenes, Yersinia enterocolitica, and Campylobacter
jejuni form biofilms on food surfaces and food contact equipment (Chae and Schraft
2000, Doyle et al. 2001, Kumar et al. 1998). Recontamination can also occur in finished
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meals during storage within the plant. Therefore, it is important to analyze the effect that
the practices of various companies had on the contamination levels of the samples.
Tables 2.2 and 2.3 revealed that all meals produced by company A and F contained
higher (P < 0.05) levels of enterococci and total bacteria. Although there were some
significant differences among the companies, it is not possible to discern if one company
was any less contaminated than the others due to unequal numbers of meal types
provided by each company.
Rendered animal products are frequently contaminated with Salmonella.
Epidemiological studies also have linked human Salmonella spp. to contaminated animal
feed (Crump et al. 2002). For example, a S. enterica serotype Heidelberg outbreak in
1963 led to 77 infections from milk consumption (Knox et al. 1963). This outbreak was
linked to bovine mastitis caused by the same Salmonella serotype, which was found in
the meat and bone meal fed to the cows. Over a four month period, Salmonella was
detected in 81% of the meat meal, 40% of the feather meal, and 84.2% of the broiler
premix (meat meal as a filler) produced in Ontario feed mills (Hacking et al. 1977).
Loken et al. (1968) tested 1,395 rendered products from seven different plants and
detected the presence of Salmonella in 241 (17%) of the samples. The study also tested
the plant with environmental swabs, and Salmonella was isolated from 359/1901 (19%)
of the swabs. In 1993, a FDA study of feed samples from 78 protein-based rendering
plants detected Salmonella enterica in 56% of the 101 samples collected (McChesney et
al. 1995). A year later a FDA test of 89 samples detected S. enterica in 25% of the
samples (Crump et al. 2002). Members of the Animal Protein Producers Industry (APPI)
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tested samples weekly for Salmonella for at least 52 tests a year (Franco 2005). On
average, twenty-five percent of the samples tested positive for Salmonella. Results from
197 Salmonella-positive samples during a particular year indicated that the average
MPN/g was 16.3 with a range of 0.2 to 78.0 MPN/g (Franco 2005). Of the Salmonella
serovars found in that study, four were associated with food borne illness (S.
Typhimurium, S. Enteritidis, S. Agona, and S. Infantis). Unlike samples analyzed by FDA
studies, which had been transported and subjected to secondary contamination, the
present study analyzed the rendered animal products collected at the end of the
processing line. As compared with above surveys, the low contamination rate for
Salmonella (8.6%) and absence of E. coli in 150 meal samples analyzed may suggest that
the rendering industry has made progress toward improving the safety of animal coproducts. In addition, samples positive for Salmonella were mostly poultry meal or
feather meal. A possible explanation is that the raw poultry products may contain larger
numbers of Salmonella entering the rendering plants which would require additional heat
exposure compared to the other meal types. Therefore, the initial microbial load of raw
materials should be considered in order to produce microbiological safe meal products.
The overall goal set forth by the FDA Center for Veterinary Medicine in 1990 is for both
animal feed ingredients and the final feed to contain no detectable amount of Salmonella,
zero tolerance (Meeker 2006).
Cross-contamination may be one of the major reasons for the presence of
Salmonella in the finished products. In this study, all Salmonella isolates had D-values in
the range of 9 minutes at 55°C, 2 minutes at 60°C, and under 45 seconds at 65°C. The
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temperatures produce in the batch cookers used for meal processing reaches 121-135°C
and are maintained for 2 to 3 h, which far exceeds the maximum temperature used in this
study. At 65°C all isolates in this study were reduced by 1 log within 45 seconds
indicating that the rendering process should be sufficient in killing all Salmonella
provided that the internal temperature of the by-products reaches or exceeds the cooking
temperature. D-values for Salmonella were reported as 18-594 min at 50°C in corn flour
(van Cauwenberged et al., 1981), 55-345 min at 70°C in wheat flour (Archer at al., 1998),
and 10-115 min at 70°C in meat and bone meal (Liu et al., 1969). Apparently, the Dvalues of the Salmonella in this study are lower than those reported for Salmonella in
above dry materials, suggesting that the Salmonella contamination in rendered animal
meals is most likely a result of post-processing contamination. The PFGE was used to
characterize the Salmonella isolates within the processing plant. A comparison between
each individual set of PFGE types and what type of product that were isolated from,
where they were collected, and when they were collected revealed that there was not a
single type present in a particular plant environment over an extended period of time.
This indicates that the likely source of contamination is the raw animal by-products due
to the fact it is a consistent incoming new source for contamination.
Enterococcus spp. is widely distributed in the environment and animals.
Enterococci also have been consistently isolated from the carcass of beef, poultry, and
pork meat (Franz et al. 2003). Knudtson and Hartman (1993) reported that pig carcasses
from three abattoirs were contaminated with enterococci at 4~8 log CFU per 100 cm2 of
the carcass surface, with E. faecium and E. faecalis as the dominant species. Enterococci
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being found in rendered meals may be less surprising than other bacterial contamination
due to the fact that enterococci are heat tolerant. A few studies previously reported that
Enterococcus spp. was detected in rendered animal meals (Cullen et al. 2003, and
Schwalbe et al. 1999). A 2003 national survey conducted by the FDA was performed on
122 samples (MBM 72, Blood 16, Bone 2, Feather 10, Poultry 17, and Fish 5) (Cullen et
al. 2003). Of these, 84% of the samples contained Enterococcus spp. which were
identified as E. faecium (86.5%), E. faecalis (7.5%), E. gallinarum (2%), E. hirae (1.5%),
and E. avium (0.5%).

The present study revealed a similar contamination rate by

enterococci (81.3%) with a range from below the detection limit (<1.40 log CFU/g) to
5.70 log CFU/g. MIC results revealed that VRE was present in the rendered products but
with low prevalence (2%). In addition, none of the VRE isolates were E. faecalis or E.
faecium. The vanA and vanB genes confer high levels of resistance (≥64µg/ml) and are
the only two resistance genes that have been associated with plasmids. Due to the low
MIC for vancomycin, the VRE isolates were assumed not to posses the vanA or vanB
genes, suggesting a low possibility that there is transference of the vancomycin resistance
genes between other species found in the rendered meal (Gilmore 2002). The absence of
the vanA and vanB gene was then confirmed by PCR analysis.
This study has provided some baseline data on microbiological contamination
levels in fresh rendered meals. These results more accurately represent the microbial
load in rendered products than previous studies since all samples were taken directly
from the production lines before the rendered meals could be mixed with any other feed
components in a feed mill. Although avoiding the contamination of finished animal
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meals is difficult in post-production shipment and reformulation, using heat tolerant
enterococci as a marker for bacterial load may help the industry to determine if the meal
products have been heated adequately or have been contaminated by raw materials or the
processing environment. Based on the low thermal resistance of Salmonella isolates
tested in this study, the heat treatment process used by the rendering industry appears to
be adequate in eliminating bacterial contamination in the product; therefore the
Salmonella contamination is most likely resulting from post-processing contamination.
Overall, the low prevalence of Salmonella contamination and absence of E. coli in all
samples indicate that the rendering industry has microbiologically improved the products.
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Figure Legend
Fig.2.1: Total bacterial and enterococci counts for six meal types. Reported values are
expressed as the mean ± standard deviation. The different letters above each bar are used
to indicate the significant (P < 0.05) differences between the counts of the meal types.
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Table 2.1. Moisture content and pH level per meal type
Meal Type

Moisture % (mean ± std dev)

pH (mean ± std dev)

Feather (n=30)

5.99 ± 2.48A*

6.20 ± 0.39B

Meat (n=14)

2.50 ± 1.49C

6.38 ± 0.58B

MBM (n=37)

2.90 ± 1.23C

6.16 ± 0.52B

Poultry (n=51)

3.21 ± 1.15BC

6.41 ± 0.28B

Blood (n=12)

4.94 ± 2.17AB

7.36 ± 1.08A

MBM-P (n=6)

4.04 ± 2.41BC

6.37 ± 0.29B

*Means with different superscripts are significantly different (P < 0.05) among meal types.
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Table 2.2. Total bacterial counts of rendered animal meals produced by 12 companies
Total bacterial counts (log CFU/g)
Company

Feather (n=30)

Meat (n=14)

MBM (n=37)

MBM-P (n=6)

Poultry (n=51)

Blood (n=12)

A

4.54 ± 0.71AB*

4.78 ± 0.62A

N/A

N/A

4.59 ± 0.87AB

N/A

B

3.68 ± 0.26B

4.80 ± 0.62A

N/A

N/A

4.52 ± 0.65AB

N/A

C

N/A**

N/A

N/A

3.98 ± 0.64

N/A

N/A

D

N/A

2.61 ± 0.46B

5.04 ± 0.64A

N/A

N/A

N/A

E

N/A

N/A

4.76 ± 0.69A

N/A

N/A

N/A

F

5.38 ± 0.86A

N/A

N/A

N/A

5.52 ± 0.38A

N/A

G

N/A

N/A

4.61 ± 0.34A

N/A

N/A

N/A

H

4.65 ± 0.52AB

3.71 ± 0.90AB

4.11 ± 0.70AB

N/A

3.86 ± 0.83B

5.91 ± 0.79

I

N/A

N/A

3.98 ± 0.69AB

N/A

N/A

N/A

J

N/A

N/A

2.20 ± 0.38B

N/A

N/A

N/A

K

N/A

3.99 ± 0.21AB

5.04 ± 1.09A

N/A

N/A

N/A

L

N/A

N/A

4.24 ± 0.94AB

N/A

N/A

N/A
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*The different letters in each column are used to indicate the significant differences (P<0.05) between the companies for that given meal type.
**N/A means that there were no samples of that meal type from the corresponding company

Table 2.3. Enterococci counts of rendered animal meals produced by 12 companies

Enterococci counts (log CFU/g)
Company

Feather (n=30)

Meat (n=14)

MBM (n=37)

MBM-P (n=6)

Poultry (n=51)

Blood (n=12)

A

2.94 ± 0.78A*

3.16 ± 0.45A

N/A

N/A

2.27 ± 1.26AB

N/A

B

2.38 ± 0.38A

3.10 ± 0.45A

N/A

N/A

2.95 ± 0.76A

N/A

C

N/A**

N/A

N/A

1.15 ± 1.03

N/A

N/A

D

N/A

0.57 ± 0.84A

2.18 ± 0.90AB

N/A

N/A

N/A

E

N/A

N/A

2.32 ± 1.10AB

N/A

N/A

N/A

F

2.83 ± 1.61A

N/A

N/A

N/A

3.35 ± 0.07A

N/A

G

N/A

N/A

2.88 ± 0.20A

N/A

N/A

N/A

H

2.58 ± 1.06A

1.78 ± 1.51A

0.97 ± 1.41AB

N/A

1.16 ± 1.38B

2.97 ± 1.53

I

N/A

N/A

1.57 ± 1.38AB

N/A

N/A

N/A

J

N/A

N/A

BLDB

N/A

N/A

N/A
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K

N/A

BLDA***

3.21 ± 0.80A

N/A

N/A

N/A

L

N/A

N/A

2.63 ± 1.33AB

N/A

N/A

N/A

* Means with different superscripts are significantly different (P < 0.05) between the companies for that given meal type.
**N/A means that there were no samples of that meal type from the corresponding company.
***BLD, Below the minimum detection limit (100 CFU/g).

Table 2.4. Percentages of samples of each meal type that was positive for Salmonella, enterococci, and coliforms
% Salmonella (n)

% enterococci (n)

% coliforms (n)

Feather (n=30)

6.7(2)

96.7(29)

6.7(2)

Meat (n=14)

7.1(1)

64.3(9)

0(0)

MBM (n=37)

8.1(3)

75.7(28)

2.7(1)

Poultry (n=51)

13.7(7)

78.4(40)

2.0(1)

Blood (n=12)

0(0)

91.7(11)

0(0)

MBM-P (n=6)

0(0)

83.3(5)

0(0)

Total (n=150)

8.7(13)

81.3(122)

2.7(4)

1
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Table 2.5. D-values and z-values of Salmonella Isolates
D-value (min) at given temperature
Isolate

Serotype

55°C

60°C

B111419*

Enteritidis

10.12 ± 0.62A

2.47 ± 0.64A 0.50 ± 0.12A

7.66

23B2

Senftenberg

9.27 ± 0.43A

2.07 ± 0.28A 0.36 ± 0.18A

7.09

98

Idikan

9.30 ± 1.66A

2.28 ± 0.53A 0.36 ± 0.21A

7.08

214

Mbandaka

9.76 ± 1.43A

2.19 ± 0.71A 0.43 ± 0.13A

7.37

222

Banana

9.47 ± 0.82A

2.08 ± 1.03A 0.35 ± 0.17A

6.98

223B

Demerara

9.99 ± 0.42A

2.15 ± 1.02A 0.40 ± 0.14A

7.16

1

* Isolate provided by SC DHEC

2

** Means with different superscripts are significantly different (P < 0.05)
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65°C

z-value (°C)

Figure 2.1

Total bacterial and enterococci counts (Log CFU/g)
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CHAPTER THREE
REDUCTION OFSALMONELLA ON ENVIRONMENTAL SURFACES WITH
BACTERIOPHAGE TREATMENT

Abstract
A previous study has suggested that the presence of Salmonella in animal meal is due to
post processing contamination. The objective of this study was to determine if a bacteriophage
cocktail could be used to reduce the risk of cross-contamination by reducing Salmonella levels
on environmental surfaces found within a rendering facility. A cocktail of five bacteriophages
was isolated and purified for two dominant Salmonella serotypes (Enteritidis and Typhimurium)
and three other serotypes (Mbandaka, Johannesburg, and Idikan) that were previously isolated
from finished rendered products. These Salmonella serotypes were treated with the
bacteriophage cocktail at varying concentrations to determine the optimal multiplicity of
infection (MOI). The optimized cocktail was then used to treat the attached Salmonella cocktail
and S. Enteritidis within a single and double species biofilm on templates of steel, plastic, cement
and rubber at 20°, 30°, and 40°C. The bacteriophage cocktail was found to be most effective at a
MOI of 10. Bacteriophage treatment of the surface materials with attached Salmonella resulted
in a ca. 2 log decrease in the Salmonella count at 40° and 30°C, and ca. 1 log CFU/cm2 decrease
at 20°C for all surface materials. Bacteriophage treatment of the S. Enteritidis single-species
biofilm resulted in a ca. 1-2, 2-3, and 1 log CFU/cm2 reduction in Salmonella populations at 20,
30, and 40°C, respectively. Bacteriophage treatment of the double species biofilm at 20, 30, and
40°C resulted in reduction of the Salmonella populations by ca. 0.5, 1.5-2.0, and 0.5 log
CFU/cm2. Overall, the bacteriophage treatment was most effective at 30°C under all test
conditions. These results demonstrated that a bacteriophage cocktail significantly reduces levels
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of Salmonella contamination on environmental surfaces, and may potentially decrease the
incidence of cross-contamination in rendering facilities.
Introduction
Annually, the U.S. rendering industry produces ca. 11.2 billion pounds of protein and
10.9 billion pounds of fats. About 85% of these products are then used in the production of
animal feed ingredients (Meeker and Hamilton, 2006). While rendered by-products have many
uses, the primary usage is as an additive to animal feed. The contamination of the feed can serve
as a vehicle for pathogenic bacteria, such as Salmonella, to enter the food chain (Crump et al.,
2003; Knox et al., 1963). This was demonstrated by a S. Heidelberg outbreak in 1963 that was
traced back to milk produced from cows infected with the serotype. Microbiological analysis
revealed that the source of the infection in the cattle was the meat and bone meal used as an
additive in the feed (Knox et al., 1963).
The presence of Salmonella has been documented in finished rendered by-products as
well as in enivornmental swab samples from the rendering facilities (Kinley et al., 2009; Hofacre
et al., 2001; Loken et al., 1968). Troutt et al. (2001) detected 12 different serotypes of
Salmonella spp. in raw materials derived from animal production and processing, materials from
the cooking/expelling process, and in final rendered products. Recently, in an analysis of ca. 200
rendered animal products collected from 12 processing plants in the U.S., we detected 13
Salmonella serotypes with an overall contamination rate of 8.7% (Kinley et al., 2009). Four
serotypes, Johannesburg, Oranienburg, Putten, and Senftenberg, detected matched those reported
by Troutt et al. (2001).
It is likely that the presence of Salmonella in rendered animal by-products is due to postprocessing contamination (Kinley, 2009). To prevent cross-contamination by Salmonella in the
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rendering environment, the most commonly used treatments on surfaces include using chemical
sanitizers (bleach and trisodium phosphate) or in rendered animal meal by adding chemical or
biological feed additives such as Sal Curb®, propionic acid, sorbic acid, acetic acid, and benzoic
acid (Larsen et al., 1993).
Bacteriophages, viruses of specific bacterial hosts, have been used as a biological control
method for various applications. Several studies have demonstrated that bacteriophage treatment
can be very effective against Salmonella contamination. Modi et al. (2001) demonstrated that the
addition of bacteriophage to a cheddar cheese starter culture significantly reduced the risk of
contamination in the final product. Whichard et al. (2003) reported that Felix 01 bacteriophage
can be used to control S. Typhimurium contamination on chicken frankfurters. A study by
Leverentz et al. (2001) reported that bacteriophages reduced Salmonella contamination on fresh
cut honey-dew melon by 3.5 logs at 5°C and 10°C, and a 2.5 log reduction at 20°C. Additionally,
the simultaneous use of two different bacteriophages against three Salmonella serotypes has been
shown to reduce Salmonella populations in sprout seeds by ca. 0.5 log (Pao, 2004). Currently,
there is a lack of information on bacteriophage application in rendering environments or in
finished animal by-products.
The purpose of this study was to develop a bacteriophage cocktail capable of effectively
reducing Salmonella contamination on environmental surfaces found within the rendering plant
environment.
Materials and Methods
Bacteriophage isolation. Bacteriophages were isolated from raw chicken offal using 12
Salmonella serotypes (Senftenberg, Oranienburg, Idikan, Johannesburg, IIIa. 42: z4, z23,
Banana, Demerara, Putten, Molade, Montevideo, Mbandaka, Livingstone, and Amsterdam)
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previously isolated from finished rendered by-products as host strains. Each individual culture
was mixed with the raw material and double strength tryptic soy broth (DS-TSB, BectonDickinson and company, Sparks, MD), and incubated for 24 h at 37°C. The culture was then
centrifuged and the supernatant was filtered using a 0.2 µm syringe filter (VWR). The
supernatant was spot plated onto tryptic soy agar (TSA, Becton-Dickinson and Company) with
an overlay containing the respective Salmonella serotype used to propagate the bacteriophage.
The resulting plaques were removed using a sterile 1 ml pipette and suspended in sterile SM
buffer (5.8g l-1 NaCl, 2g l-1 MgSO4*7H20, and 1M pH 2.5 50ml l-1 Tris-HCl). The bacteriophages
were purified by repeating the process of suspending the agar plugs in sterile SM buffer for 1 h
and replating on a TSA plate overlayed with the respective Salmonella serotype twice. After
purification, the resulting plaques were suspended in SM buffer and incubated at 4°C for 24 h.
Following incubation, the suspension was removed with a sterile pipette and syringe filtered (0.2
µm). The resulting bacteriophage suspension was stored at 4°C and used to produce stocks.
Bacteriophage FO was kindly provided by the University of Calgary and a stock solution
was prepared as described above. The host strain for this bacteriophage during this study was S.
Idikan.
Bacteriophage preparation. The host strain for each bacteriophage was grown in tryptic
soy broth (TSB) overnight, and one milliliter of the culture was inoculated into 250 ml of fresh
TSB. The bacteriophage was added to the TSB at a multiplicity of infection (MOI) of 0.1, and
the suspensions were incubated with agitation (3 rpm) at 37°C for ca. 4-5 h. Chloroform was
added to the suspensions, and then after incubation at 37°C for 10 min, the suspension was
vacuum filtered using a disposable water filtration unit (Nalgene, 0.45µm). The filtered solution
was centrifuged at 70,000 x g for 90 min. The pellet was resuspended in 5 ml of SM buffer, and
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incubated at 37°C for 1 h. The filtered bacteriophage solution yielded a titre of 1010 to 1012
PFU/ml.
Transmission electron microscopy: Copper grids (400 mesh, EMS, Hatfield, PA) were
coated with 0.5% formvar dissolved in dichloroethane (Fischer, Fairlong, NJ). Dried grids were
placed on parafilm (American National Can, Menasha, WI) and 5 µl of phage solution (1010
PFU/ml) was pipetted on the surface for 1 min. The liquid was drawn off with filter paper and
the grid was stained for 30 seconds with 5 µl of 0.5% phosphotungstic acid (PTA; EMS,
Hatfield, PA) or 2% uranyl acetate (UA; EMS, PA). Grids were air-dried and viewed on a
Hitachi H-7600 electron microscope (Hitachi, Tokyo, Japan) at 120-keV accelerating voltage.
Bacteriophage cocktail optimization. Two commonly isolated Salmonella serotypes
(Typhimurium and Enteritidis) and three previously isolated serotypes from rendered products
(Idikan, Mbandaka, and Johannesburg) were used for this study. For each of these isolates, at
least one bacteriophage was selected based on a series of host range testing. Briefly, all
bacteriophages were spotted onto TSA overlayed with every Salmonella serotype being tested.
The lytic activity of each bacteriophage was determined by the amount of lysis observed on the
plate. Before combining the bacteriophage isolates into a cocktail, the MOI needed for complete
lysis was determined for each bacteriophage individually by plating a series of dilutions of each
bacteriophage onto a TSA plate overlayed with its individual targeted Salmonella serotype. The
lowest concentration of bacteriophage that resulted in complete lysis was then used to compose
the bacteriophage cocktail.
To determine if the cocktail was effective, each Salmonella serotype was diluted in TSB
and transferred to a 96-well microplate. SM buffer was added to the control group and each
bacteriophage was added to the serotype it was selected for at the previously determined
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concentration. The microplate was incubated at room temperature and O.D. readings were
determined at 600 nm using a µQuant™ spectrophotometer (Bio-Tek Winooski, VT) at set time
intervals. This procedure was carried out on each serotype and a mixture of the serotypes using
the bacteriophage cocktail at MOIs of 1, 10, and 50.
Attaching Salmonella to environmental surface materials. Stainless steel, concrete,
high density polyethylene (HDPE) plastic, and rubber were cut into 25 cm2 templates. The
stainless steel templates were washed with acetone, etched by submerging the templates in 5N
HCl for 15 min, washed with Micro-90® (International Products Association Burlingotn, NJ)
detergent, and rinsed with sterile nanopure water (Joseph et al., 2001). The concrete templates
were cleaned using a scrubbing brush and rinsed with sterile nanopure water. Both HDPE plastic
and rubber templates were washed with a detergent and rinsed with sterile nanopure water.
Each dry template was inoculated with the mixture of 5 Salmonella serotypes by
spreading the suspension over the entire template surface using a sterile inoculating loop to yield
an initial concentration of ca. 105 CFU/cm2. The templates were allowed to air-dry for ca. 6 h at
room temperature inside of a purifier class II biosafety cabinet (Labconco Kansas City, MO). To
remove unattached cells, templates were washed once with 10 ml sterile phosphate buffered
saline (PBS). The templates were transferred to petri dishes containing a mixture of TSB and SM
buffer using sterile forceps.
The effect of nutrient debris on surfaces with attached bacterial cells was also studied.
The Salmonella cocktail was mixed into the liquefied raw material (raw chicken offal mixed and
ground with sterile saline 1:1), spread over the templates, and air-dried to yield an initial
concentration of 105 CFU/cm2, as described above.
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Biofilm formation on the environmental surfaces. A green fluorescent protein (gfp)
labeled S. Enteritidis H4717 was used for biofilm studies. This organism contains a plasmid
encoded with ampicillin resistance 100µg/ml. To produce a single species biofilm, the templates
were submerged in 30 ml of 20% TSB with ampicillin (100 µg/ml) that was inoculated with the
S. Enteritidis at a concentration of 105 CFU/ml and incubated at 30°C for 6 days. The templates
were removed every other day, washed with sterile PBS, and placed back into fresh 20% TSB.
To produce the multiple species biofilm, the templates were submerged in 30 ml of 20% TSB,
which was inoculated with the gfp-labeled S. Enteritidis H4717 and Pseudomonas aeruginosa at
a concentration of 105 CFU/ml for each culture, and incubated at 30°C for 6 days. The templates
were handled in the same manner as those with the single species biofilm.
Bacteriophage treatment of artificially contaminated environmental surfaces. For
bacteriophage treatment of templates with attached cells, the templates were suspended in the
mixture of SM buffer and TSB inside a petri dish. The bacteriophage cocktail was added to the
solution at a final concentration of 106 PFU/ml. The control templates were treated with SM
buffer instead of the bacteriophage cocktail. The templates were incubated at 20, 30, and 40°C,
and removed at pre-determined time intervals. At each sampling time, the surfaces of the
templates were swabbed thoroughly using a sterile cotton swab, and then transferred into sterile
saline. The suspension was centrifuged for 10 min at 5,100 rpm to separate bacterial cells from
remaining bacteriophage particles. The supernatant was decanted and bacterial cells were
resuspended and serially diluted with sterile saline. All dilutions were spiral-plated onto TSA
with an Autoplate 4000 (Spiral Biotech Norwood, MA), and incubated at 37°C for 24 h.
Biofilm templates were analyzed using the same procedure as described above, with one
exception. After the addition of the bacteriophage cocktail, the templates were either incubated at
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37°C for 15 min to produce biofilms with absorbed bacteriophage, or the templates were directly
incubated at the test temperatures (unabsorbed bacteriophage). Salmonella populations were
determined as described above. When analyzing the multiple species biofilm containing P.
aeruginosa, Salmonella was enumerated with xylose lysine tergitol-4 plates (XLT-4, BectonDickinson and company).
Confocal imaging of the surfaces with single and multi-species biofilms treated with
bacteriophages. After bacteriophage treatment at 30°C, templates containing biofilm were
viewed using a confocal scanning laser microscope (LSM 510, Karl Zeiss, Germany) equipped
with an argon laser (458, 477, 488, and 514 nm) and two HeNe lasers (543 and 633 nm) along
with untreated templates to visualize the effect the bacteriophage had on the biofilm. The PMT1
emmision filters were set at band pass (BP) of 505-520 nm and long pass filter (LP) of 580 nm to
detect the gfp-labeled Salmonella cells.
Chemical treatment of environmental surfaces artificially contaminated with
Salmonella. For comparative purposes, two chemical sanitizers were used to treat the
environmental surfaces containing the attached Salmonella, attached Salmonella with organic
material, single-species biofilm, and double-species biofilm. The two chemicals were bleach
solution (Clorox®), containing 200 ppm sodium hypochlorite, and 12% trisodium phosphate
(TSP). The treatment procedure was performed as described for the bacteriophage treatment,
except chemical sanitizers were substituted for the bacteriophage cocktail.
Statistical analysis. All plate count data were converted into log values. The mean
Salmonella counts and standard deviations were determined for control and experimental
samples for each method of treatment at all temperatures. The data were subjected to analysis of
variance with a test criterion (F statistic) and type I error controlled at P = 0.05. The Tukey’s
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multiple comparison procedure of the Statistical Analysis System (SAS 2001, Cary, NC.) was
used to compare all pairs of means when the test criterion for the analysis of variance was
significant.
Results
Bacteriophages were isolated from raw chicken offal for every Salmonella serotype used (n=12)..
The number of bacteriophages isolated for each serotype is shown in Table 1. Two of those
bacteriophages (JC1 and MbE2) were selected to produce a cocktail based on their lytic activity against
S. Typhimurium, S. Enteritidis, S. Idikan, S. Mbandaka, and S. Johannesburg. The other three
bacteriophages included 2 previously isolated from raw sewage (H3353S6p2 and H4717S5p2) and the
FO bacteriophage. The TEM images of 4 of the bacteriophages (excluding FO) are presented in Fig. 1.

The presence of a contractile tail for M226 and H4717S5p2 suggest that they belong to the family
of Myoviridae. Bacteriophage J161 and H3353S6p2 had flexible non-contractile tails and were of
the family Siphoviridae.
The MOI optimization study indicated that increasing the MOI from 1 to 10 enhanced the
lytic activity of the bacteriophage; however, a MOI of 50 did not increase (P>0.05) the efficacy
of the bacteriophage cocktail (Fig. 3.2a). MOI optimization also revealed that the cocktail’s lytic
activity was only sustained for a 12 h period. The addition of a different bacteriophage cocktail
with a MOI of 10 was shown to extend the lytic activity for an additional 12 h (Fig. 3.2b).
An initial trial was conducted to determine the effect of residual bacteriophage particles
on Salmonella enumeration following bacteriophage treatment. Following treatment on stainless
steel at 30°C, Salmonella populations were compared when the sample suspension was directly
plated with when it was centrifuged to remove the remaining bacteriophage. The results (Table
3.2) showed an insignificant difference (P>0.05) between the two sampling procedures; however,
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to ensure there was no prolonged effect, samples collected during the current study were
centrifuged prior to plating for Salmonella enumeration.
The bacteriophage cocktail reduced levels of the attached Salmonella on all surface
material at all tested temperatures (Fig. 3.3). Bacteriophage treatment reduced Salmonella levels
by ca. 1.0, 2.0-2.5, and 1.5-2.0 log CFU/cm2 at 20, 30, and 40°C, respectively, within 6 h for all
templates. The level of reduction was significant (P<0.05) for all temperatures on all surfaces
(Table 3.3). The presence of an organic layer had no observed effect on the efficacy of the
bacteriophage cocktail (Table 3.3). Salmonella reduction within the organic layer when treated
with the bacteriophage was also significant (P<0.05) at all temperatures and on all surfaces.
The bacteriophage cocktail was also capable of reducing the amount of Salmonella
Enteritidis H4717-gfp within an attached biofilm on all surfaces at the tested temperatures (Table
3.3). GFP-labeled S. Enteritidis H4717 was reduced by ca. 1.5-2.0, 2.0-4.0, and 1.0-1.5 log
CFU/cm2 at 20, 30, and 40°C respectively for all templates. As observed with the attached cells,
the bacteriophage cocktail reduced Salmonella levels (P<0.05) in biofilm at the tested
temperatures. Allowing absorption into the biofilm prior to incubation had no observable impact
on the efficacy of the bacteriophage (data not shown). The effect of the bacteriophage cocktail on
S. Enteritidis H4717-gfp within the biofilm can also be observed in the confocal images (Figure
3.4). On the treated slide (Fig. 3.4(c)) there is less gfp-labeled Salmonella cells detected by the
confocal microscope than seen in the control (b) and initial biofilm (a) samples.
The bacteriophage treatment of Salmonella embedded in a double species biofilm was not
as effective when compared to the bacteriophage treatment of the single species biofilm (Fig.
3.4); however, the bacteriophage still significantly reduced the level of S. Enteritidis H4717-gfp
(P<0.05) within the biofilm on all surfaces and at all temperatures. S. Enteritidis H4717-gfp was
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reduced by ca. 0.5, 1.5-2.0, and 0.5 log CFU/cm2 at 20, 30, and 40°C, respectively, for all
templates (Table 3.3). As observed with other treatments, the bacteriophage cocktail was most
effective at 30°C.
Treatment of the attached cells with the chemical sanitizers TSP and bleach solution
resulted in Salmonella counts below the detection limit (1 CFU/cm2 ) within 1 and 3 h,
respectively. In the presence of an organic layer, the attached Salmonella populations were
reduced below the detection limit within 1 h for TSP. For bleach solution treatment, there was an
initial decrease in Salmonella counts through 2 h followed by a period of growth through the
remaining 4 h of treatment. Treatment of Salmonella in single and double species biofilm
resulted in counts below the detection limit within 3 h for TSP and within 6 h for bleach solution
(data not shown).
Discussion
The presence of Salmonella spp. in finished by-products can be a result of Salmonella
surviving the heat processing or post-processing contamination. It is documented that the raw
ingredients used to produce rendered by-products are contaminated with Salmonella and
therefore serve as a potential source of cross contamination in the rendering facility (Troutt et al.,
2001; Loken et al. 1968).
If contaminated, the environmental surfaces (steel, concrete, rubber, and HDPE plastic)
can also contaminate the final products upon contact. Kusumaningrum et al. (2003) reported that
Salmonella is capable of adhering to stainless steel, and that the presence of food residues
increased the survival time of the bacteria. For example, when a low inoculum of S. Enteritidis
was spread on the stainless steel with no food particles there was a 2.2 log reduction within an
hour as compared with a 1.0 log reduction in the presence of milk residue. Additionally,
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Kusumaningrum et al. (2003) demonstrated that the S. Enteritidis could be transferred from the
steel to cucumber slices and chicken filets immediately or 15 minutes after contamination.
Identical S. Typhimurium isolates were detected on a rubber conveyor belt used to transport
manure 20 months after initial isolation (Sanvang et al., 2000), suggesting that the strain
persisted on the conveyor belt over this extended period. Loken et al. (1968) detected Salmonella
in 19% of 1901 swabs collected from the environmental surface of a rendering facility, which
further demonstrates the potential for cross contamination between the environment and finished
products.
Traditionally the environments in food processing facilities have been treated with
chemical sanitizers. These sanitizers have been effective but have some disadvantages such as
high cost, corrosiveness to machinery, inactivated by organic material, inactivated by variations
in heat and pH, and posing a potential hazard to the environment and the workers (Marriott,
1994). This warrants the development of a new means of sanitation in the food processing
industry such as bacteriophage treatment.
The use of bacteriophages offers multiple advantages: the host specificity is not likely to
select for bacteriophage resistant bacterial strains, resistance against bacteriophage does not
affect the efficacy of antibiotics given to humans, and bacteriophage mixtures can be easily
modified and rapidly developed against resistant bacteria (Kutter and Sulakvelidze, 2005). In
terms of Salmonella treatment, host specificity can be a hurdle for reducing contamination levels.
There is not a single bacteriophage capable of lysing all known serovars of Salmonella (Joerger,
2003). In fact, a particular bacteriophage may not even be capable of lysing all members of a
particular serovar. To overcome this shortcoming, a “cocktail” of bacteriophages must be
designed capable of lysing all Salmonella strains of interest (Joerger 2003). The production of an
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effective bacteriophage cocktail for Salmonella has been previously reported. Chighladze et al.
reported to have developed a bacteriophage cocktail capable of lysing 232 of 245 Salmonella
isolates composed of 21 serovars and 78 pulse field gel electrophoresis (PFGE) types (Joerger
2003).
Bacteriophage treatment for pathogen inactivation has been considered a very effective
biological control method. While the majority of research involving Salmonella treatment with
bacteriophage has focused on live animals and raw meats, it has been demonstrated that
bacteriophage treatment can be successful at controlling contamination on environmental
surfaces. Roy et al. (1993) applied a mixture of three bacteriophages (H387, H387-A, and 2671)
to treat L. monocytogenes on stainless steel resulting in a 3 log reduction of L. monocytogenes
populations. There have been limited reports on the treatment of Salmonella on environmental
surfaces by bacteriophages; however, Chigaldze et al. were able to reduce Salmonella to below
the detectable limit within 48 h of bacteriophage treatment on inanimate surfaces (Joerger,
2003). In the current study, the bacteriophage cocktail was able to reduce Salmonella by as much
as 2.5 log at 30°C. MOI optimization suggested that in order for bacteriophages to propagate and
lyse the host, the bacterial cells should be actively growing. This could be explained by the
reliance of bacteriophages on host cell machinery for replication (Kutter and Sulakvelidze,
2005). This could also explain the variation in the efficacy of the bacteriophage treatment based
on the environmental temperature.
MOI optimization during this study revealed that the bacteriophage cocktail used was
capable of reducing Salmonella levels at a low ratio (MOI=10), but the lytic effects of the
cocktail diminished after ca. 12 h of treatment (Fig. 3.2a). McLaughlin et al. (2007) reported that
a single bacteriophage was incapable of eliminating Salmonella due to selection of resistant

123

strains. The presence of a resistant strain within the Salmonella spp. offers a possible explanation
for the decreased lytic activity. While a short lytic period is not desirable, in this study, the
addition of a second cocktail composed of 5 different bacteriophages resulted in suppression of
Salmonella growth for an additional 12 h (Fig. 3.2b).
In the natural environment, bacteria may be attached to environmental surfaces as
components of a large microbial network known as a biofilm. A biofilm can be composed of one
or various species of bacteria and their excreted products. Salmonella spp. are capable of
producing biofilm on surfaces such as plastic, steel, and cement (Jones and Bradshaw, 1996;
Joseph et al., 2002), which are commonly found in a rendering facility. Biofilms are potential
continuous sources for cross-contamination between contact surfaces and the finished rendered
by-products.
In order for a bacteriophage to lyse bacteria within a biofilm the target bacteria have to
be susceptible to the bacteriophage being used. Also, the exopolysaccharide (EPS) produced by
the biofilm must be susceptible to degredation by the polysaccharide depolymerase produced by
the bacteriophage. The effects of bacteriophage treatment on single species biofilms have been
well documented. Using microscopy, Doolittle et al. (1995) discovered that the matrix produced
by an Escherichia coli biofilm was ineffective in preventing bacteriophage T4 from infecting the
bacterial cells. Karunasagar (2007) demonstrated that when using a bacteriophage concentration
of 105 PFU/ml, Vibrio harveyi counts were reduced nearly 1 log CFU/cm2 after 18 h on high
density polyethylene (HDPE) plastic. Bacteriophage KH1 was able to significantly reduce
(P<0.05) E. coli O157:H7 counts in biofilms from an initial concentration of 4.0 log CFU per
coupon to 2.8 log CFU per coupon and 2.7 log CFU per coupon after 24 and 48 h of
bacteriophage treatment, respectively (Sharma et al., 2005). The results from our study revealed
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that Salmonella levels can also be reduced in a single species biofilm through bacteriophage
treatment. Under optimal conditions (30°C), the bacteriophage cocktail was capable of reducing
S. Enteritidis within the biofilm by ca. 3 log CFU/cm2. While the level of reduction observed in
this study is in agreement with other studies, the effect observed during the current study
occurred within 6 h as opposed to the 18-48 h range reported by previous studies.
Biofilms composed of multiple bacterial species may contain additional barriers such as
bacterial cell co-aggregation (Rickard et al., 2003; Sutherland 2004). Storey and Ashbolt (2001)
attempted to treat biofilm composed of Bacteroides fragilis and E. coli in an urban water
distribution system with bacteriophages. The bacteriophages were initially taken in by the
biofilm on stainless steel and polythene surfaces; however, following the initial treatment,
bacteriophage populations began to decrease rapidly, suggesting that the bacteriophages were
entering the biofilm matrix but not infecting the host cells. Our current study also demonstrates
that the presence of multiple species within a biofilm may create additional barriers for the
bacteriophage treatment, as the addition of P. aeruginosa to the biofilm decreased the amount of
Salmonella reduction as compared with single-species biofilm.
In this study the effectiveness of the bacteriophage cocktail was also compared to that of
commonly used chemical sanitizers in order to determine if the bacteriohage cocktail would
make an adequate replacement. Bleach solution (200 ppm sodium hypochlorite) and TSP were
selected based on a survey of participating rendering facilities (Robertson, 2008). Our results
indicated that both the bleach solution and TSP were more effective at reducing Salmonella
contamination than the bacteriophage treatment. Salmonella inactivation by both sanitizers was
achieved within 1 h for both attachment studies and within 3 h for both the single and double
species biofilm. The one exception was that the bleach solution was ineffective at treating the
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attached Salmonella cells in the presence of organic material, which can be explained by the fact
that chlorine based compounds have a high affinity to bind to organic material. Once bound to
organic material the compounds are inactivated (Guthrie, 1992). As compared with chemical
sainitizers, bacteriophages are not corrosive to quipment and are not harmful to the environment
like many chemical sanitizers do (Kutter and Sulakvelidze, 2005). The bacteriophages are cost
efficient since they are self replicating and only require actively growing host cells. Furthermore,
the rendering plant also has a continuous source for new bacteriophages in the incoming raw
material, as a bacteriophage capable of lysing all Salmonella serotypes of interest was easily
isolated from the raw material as demonstrated by this study.
This study has demonstrated that a bacteriophage cocktail can be used to reduce
Salmonella on the surfaces found within a rendering facility at various temperatures and in
various forms of attachment. Up to 3 log CFU/cm2 of Salmonella can be inactivated by the
bacteriophage cocktail within 6 h of treatment when the temperature was maintained between 20
and 40°C. By reducing or eliminating the amount of Salmonella contamination found within the
rendering environment, the bacteriophage treatment may decrease the potential for crosscontamination leading to a microbiologically safe animal meal. The treatment can be used
without any concern for potential hazards to the finished animal meal, rendering equipment,
humans, or the animals consuming the finished feed. While more work is needed with multispecies biofilm, the data presented in this study suggests that bacteriophage treatment can be
used by the rendering industry to lower contamination levels of not only Salmonella but any
pathogens of concern.
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Figure Legend

Fig. 3.1. Transmission electron microscopic images of individual bacteriophages. J161 (a), M226
(b), H3353S6p2(c), and H4717S5p2 (d) observed at 100,000X.
Fig. 3.2. MOI optimization of the bacteriophage cocktail with one application of cocktail (a) and
two cocktails (b). Control (×), MOI 1 (▲), MOI 10 (■), and MOI 100 (♦). “ “ on (b) signals the
addition of the 2nd cocktail.
Fig. 3.3. Bacteriophage treatment of Salmonella attached to concrete (a), plastic (b), rubber (c),
and steel (d) at 20° (♦), 30° (▲), and 40°C (●). Control and treatment were plotted in solid and
dashed lines, respectively.
Fig. 3.4. Confocal images of single and double species biofilm on stainless steel at 0h (a, d), 6h
of control (b, e), and 6h of bacteriophage treatment (c, f).
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Table 3.1. Bacteriophages isolated from chicken offal
Offal Sample

Treatments

A

A1

5*, 6, 7, 12, 16

IA1, JA1, LA1, OA1, TA1

A2

7, 12, 16

LA2, OA2, TA2

B1

1, 6, 7, 10, 11, 12, 16

AB1, JB1, LB1, MolB1, MonB1, OB1, TB1

B2

1, 3, 6, 7, 10, 11, 12, 16

AB2, DB2, JB2, LB2, MolB2, MonB2,

C1

2, 6, 7, 12, 13, 16

BC1, JC1**, LC1, OC1, PC1, TC1

C2

2, 3, 7, 12, 13, 16

BC2, DC2, LC2, OC2, PC2, TC2

D1

1, 3, 5, 6, 7, 9, 12, 13, 16

AD1, DD1, ID1, JD1, LD1, MbD1, OD1, PD1, TD1

D2

1, 3, 7, 9, 12, 13, 16

AD2, DD2, LD2, MbD2, OD2, PD2, TD2

E1

1, 2, 3, 6, 7, 9, 12, 13 ,15, 16

AE1, BE1, DE1, JE1, LE1, MbE1, OE1, PE1, SE1, TE1

E2

1, 2, 3, 5, 6, 7, 9, 12, 13, 15,
16

AE2, BE2, DE2, IE2, JE2, LE2, MbE2, PE2, SE2, TE2

F1

2, 3, 6, 7, 12, 16

BF1, DF1, JF1, OF1, TF1

F2

2, 3, 6, 7, 12, 16

BF2, DF2, JF2, LF2, OF2, TF2

B

C

D

E

F

Serotypes Affected

Bacteriophage ID

*Salmonella serotpye: 1. S. Amsterdam, 2. S. Banana, 3. S. Demerara, 4. S. Enteritidis, 5. S. Idikan, 6. S. Johannesburg, 7. S. Livingstone, 8-9. S. Mbandaka,
10. S. Molade, 11. S. Montevideo, 12. S. Oranienburg, 13. S. Putten, 14-15. S. Senftenberg 16. S. Typhimurium
**Bold print indicates the bacteriophage was used during treatment studies
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Table 3.2. Effect of residual bacteriophage on Salmonella enumeration
Time (h)

Non-centrifuged

Centrifuged

1

2.93*±0.07A**

3.09±0.07A

2

2.76±0.06A

2.85±0.08A

3

2.69±0.09A

2.71±0.06A

4

2.41±0.12A

2.52±0.08A

5

2.28±0.05A

2.37±0.05A

6

2.19±0.09A

2.24±0.05A

*log CFU/cm2

** The letters represent the levels of significant difference (P<0.05) between the two test groups
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Table 3.3. Salmonella levels following 6 h of bacteriophage treatment (MOI 10) on various surface templates as affected by temperature
20°C

30°C

40°C

Contamination

Surface

Control

Treatment

Control

Treatment

Control

Treatment

Attachment
in buffer

Concrete

3.67*±0.15A**

2.50±0.22B

3.97±0.16A

1.97±0.18B

3.92±0.13A

2.35±0.18B

Plastic

3.68±0.22A

2.34±0.13B

4.19±0.09A

2.11±0.13B

3.84±0.19A

2.06±0.13B

Rubber

3.47±0.20A

2.29±0.06B

4.04±0.14A

1.56±0.20B

3.90±0.10A

2.03±0.15B

Steel

3.55±0.09A

2.25±0.13B

4.22±0.11A

2.22±0.20B

3.92±0.19A

2.18±0.14B

Concrete

3.84±0.09A

2.65±0.19B

4.06±0.10A

1.79±0.15B

4.17±0.12A

2.95±0.14B

Plastic

3.56±0.17A

2.34±0.12B

3.82±0.23A

1.87±0.14B

3.88±0.10A

2.41±0.19B

Rubber

3.62±0.17A

2.59±0.21B

4.43±0.22A

1.78±0.20B

3.96±0.23A

2.16±0.12B

Steel

4.03±0.10A

2.62±0.16B

4.28±0.08A

2.21±0.12B

4.03±0.10A

2.39±0.10B

Concrete

5.03±0.10A

3.59±0.12B

5.46±0.17A

2.47±0.10B

4.48±0.12A

3.30±0.19B

Plastic

5.02±0.09A

3.24±0.15B

5.79±0.10A

2.06±0.15B

4.78±0.09A

3.19±0.08B

Rubber

5.05±0.09A

3.43±0.14B

5.52±0.12A

3.73±0.16B

4.47±0.10A

3.20±0.14B

Steel

4.97±0.14A

3.01±0.08B

5.63±0.19A

2.82±0.19B

4.57±0.11A

3.36±0.17B

Concrete

4.85±0.18A

4.50±0.14B

5.24±0.12A

3.74±0.15B

4.84±0.16A

4.41±0.19B

Plastic

4.56±0.09A

4.20±0.09B

4.89±0.16A

3.05±0.10B

4.53±0.10A

4.17±0.12B

Attachment
in organic layer

Single Species
Biofilm

Double Species
Biofilm
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1
2
3

Rubber

4.47±0.11A

4.07±0.12B

4.97±0.14A

3.44±0.15B

4.59±0.16A

4.18±0.08B

Steel

4.78±0.22A

4.49±0.12B

4.84±0.13A

3.04±0.09B

4.43±0.10A

4.04±0.13B

*Salmonella counts CFU/cm2
**The different letters represent significant differences (P<0.05) between the control group and treated group after 6 h incubation
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Figure 3.1
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Figure 3.2
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CHAPTER 4
BACTERIOPHAGE TREATMENT OF RAW CHICKEN OFFAL, RENDERED ANIMAL
MEALS, AND MICE CHALLENGED WITH SALMONELLA ENTERITIDIS

Abstract
The objectives of this study were to determine if a bacteriophage cocktail could be used
either to reduce Salmonella in the raw material used by the rendering industry or as a feed
additive to reduce Salmonella infection in animals. A cocktail of 5 previously isolated
bacteriophages with a multiplicity of infection (MOI) of 10 and 100 was used to treat sterile and
non-sterile raw material contaminated with a Salmonella cocktail (ca. 105 CFU/g) at 20°, 30°,
and 40°C. The bacteriophage treatment reduced Salmonella levels by 2.0, 2.7, and 2.5 log CFU/g
at 20°, 30°, and 40°C in the sterile poultry offal samples, as compared with a 2.0, 2.2, and 2.2 log
CFU/g reduction, respectively, in the non-sterile samples. Bacteriophage stability testing
indicated that the titer of lyophilized bacteriophages mixed in animal meals decreased by 1.5 log
PFU/g at 30°C, while fresh bacteriophage levels decreased by ca. 0.23 log PFU/g at 4°C over 4
weeks. The lyophilized bacteriophage did not reduce Salmonella levels in the animal meals
during storage at 30°C, but Salmonella growth was slowed down during the rehydration step.
During the 4-week trial, the difference in Salmonella levels after rehydration for 24 h between
those samples treated with lyophilized bacteriophage and those not treated ranged from 0.8-1.5
and 1.0-2.0 log CFU/g when using a MOI of 10 and 100, respectively. The addition of fresh
bacteriophages to the rehydrated meals was able to reduce Salmonella levels by ca. 1.0 log
CFU/g at 30°C. The bacteriophage was also tested for reducing Salmonella infection of Balb/c
mice. Mice receiving feed supplemented with the bacteriophage cocktail (MOI of 100) showed
no signs of infections (shedding in feces or histological analysis), while mice not receiving the
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bacteriophages shed Salmonella in the feces for a period of 2.5 weeks and histological
examination revealed signs of inflammation in the liver. These results indicate that the
bacteriophage cocktail can be used to significantly reduce Salmonella levels in raw chicken offal,
which reduces the probability of cross-contamination, and can be used as an effective feed
additive if added in liquid form shortly before consumption by animals.
Introduction
In the U.S., approximately, 100 million hogs, 35 million cattle, and 8 billion chickens are
slaughtered for consumption annually, resulting in a large quantity of inedible by-products
(Meeker and Hamilton, 2006). On average, approximately 50% of an animal is inedible
(Ockerman and Hansen, 1988; Meeker and Hamilton, 2006). Of the potential treatment methods
(pyre, incineration, landfill, burial, and rendering), the rendering process is the only method that
adequately eliminates the biological risks without hazardous environmental impact (Meeker and
Hamilton et al., 2006; U.K. Department of Health, 2001).
The raw material coming into a rendering facility can be highly contaminated with
numerous human pathogens. Troutt et al. (2001) detected Clostridium perfringens, Listeria spp.,
Campylobacter spp., and Salmonella spp. in 71.4, 76.2, 29.8, and 84.5% of raw poultry offal
samples, respectively. An U.S. federal study conducted between January 1998 and December
2000 reported the following Salmonella contamination rates: 20% in broilers, 8.7% swine, and
2.7% for cows and bulls (Rose et al., 2002). The Food Safety Inspection Service (FSIS) of the
USDA reported Salmonella in ca. 16% of broiler carcasses sampled in 2005 (D’Aoust and
Maurer, 2007). Salmonella contamination levels ranged from 6.5-7.2 log CFU/g from poultry
feathers and 5.8-6.3 log CFU/g on poultry carcasses (Kotula and Pandya, 1995). Botteldoorn et
al. (2003) reported an average Salmonella contamination rate of 37% on swine carcasses at 5
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different slaughter houses. The rates of Salmonella contamination were as high as 70%
dependent upon the slaughter house and date of sampling.
While the raw material may contain Salmonella, the rendering system is adequately
designed to inactivate pathogen contamination from the raw material. The cookers used to treat
the incoming material are heated by boiler steam so that the internal temperature of the raw
material reaches 115 to 145°C (Anderson, 2006). However, Hacking et al. (1992) tested finished
meat and feather meal from Ontario rendering facilities over a four month period and found
Salmonella contamination rates of 81% and 40%, respectively. In the U.S., a FDA study
conducted by McChesney et al. (1995) detected Salmonella enterica in 56% of the 101 meal
samples tested. Our previous study demonstrated that Salmonella isolates collected from finished
rendered products were heat sensitive with an average D-value of 45 sec at 65° C (Kinley at al.,
2009), suggesting the finished products may have been contaminated with Salmonella postprocessing. This study also revealed that a persistent strain of Salmonella was not found in the
finished products of a given rendering facility using pulse field gel electrophoresis (PFGE)
analysis (Kinley et al., 2009). This suggests that the cross-contamination is resulting from a new
incoming source such as the raw material.
Regardless of the source, the finished product can serve as a reservoir for Salmonella
contamination which will then be incorporated into animal feed and into the food chain.
Epidemiological studies have linked human Salmonella spp. to contaminated animal feed
(Crump et al. 2002). For example, a S. Heidelberg outbreak in 1963 led to 77 infections from
milk consumption, which was linked to bovine mastitis caused by the same Salmonella serotype,
which was found in the meat and bone meal fed to the cows (Knox et al. 1963).
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Currently, bacterial feed contamination is treated through organic feed additives such as
Sal Curb®. Larsen et al. (1993) demonstrated that the addition of Sal Curb® to poultry feed
reduced Salmonella by ca. 2 log CFU/g. Opitz et al. (1993) further demonstrated that when
added into poultry feed Sal Curb® can significantly (P<0.05) reduce the rate of S. Enteritidis
infection in chicks; however, the levels of S. Enteritidis in the feces of infected chicks (1.18 log
CFU/g) were not significantly less than the control. In addition to Sal Curb®, Opitz et al. (1993)
tested the potential of probiotics [Primalac®, egg powder, lactose, and Lactobacillus acidophilus
(Lactbio®)] as anti-Salmonella feed additives. They found that none of the tested additives
significantly (P<0.05) reduced the rate of S. Enteritidis infection and reduced levels in those
animals infected, which led them to conclude none of the tested additives should be solely relied
upon for prevention of S. Enteritidis infection.
An alternative to these chemical-based additives is bacteriophages. Bacteriophages,
viruses with specific bacterial hosts, have been used as a biological agent for pathogen control.
Recent studies have indicated that bacteriophages can be used as a therapeutic agent for
Salmonella. Berchieri et al. (1991) applied bacteriophages to reduce the level of Salmonella by 1
log CFU/g within 12 h in the crop, intestine and cecae of chickens.
The objectives of this study were to determine if treatment with a bacteriophage can
reduce Salmonella levels within the raw material used by the rendering industry and if a
bacteriophage cocktail can potentially be used as a feed additive to reduce Salmonella population
upon rehydration of the feed in vitro and in vivo.
Materials and Methods
Bacteriophage cocktail preparation: The bacteriophage cocktail used during this study
was composed of five bacteriophages previously isolated and purified from raw chicken offal
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(n=2), inactivated sludge (n=2), as well as the F0 bacteriophage from the University of Calgary’s
Salmonella Genetic Stock Centre (Kinley et al., unpublished). The bacteriophage stocks were
prepared and stored in sterile SM buffer (NaCl 5.8 g l-1, MgSO4·7H20 2 g l-1 & Tris-HCl 1 M, pH
2.5, 50 ml l-1).
Sample preparation: Incoming raw chicken offal was collected from a SC rendering
facility. Upon arrival at the lab, the raw material was mixed with sterile saline (1:1), and blended
in a sterile laboratory blender (Waring model 51BL30) at Hi speed for 5 min. To enumerate
Salmonella, serial dilutions of sample suspensions were made using sterile saline and spread
plated onto xylose lysine tergitol-4 (XLT-4, Becton-Dickinson and company). The blended raw
material, placed inside 50 ml sterile centrifuge tubes, was then frozen at -80°C for subsequent
bacteriophage treatment.
Bacteriophage treatment of raw materials: Half of the prepared raw samples were sent
to the physics department at Auburn University via overnight delivery, where they were
irradiated at 1.5 MRad at 6,133 R/min. Both sterile and non-sterile raw material was divided into
8 ml portions in sterile whirl-pak bags in preparation for bacteriophage treatment. Overnight
cultures of rifampin resistant (100 µg/ml) Salmonella isolates (Typhimurium, Enteritidis,
Mbandaka, Johannesburg, and Idikan) were added together as a cocktail and then mixed into the
sterile and non-sterile raw material at a final concentration of 105 CFU/ml. The bacteriophage
cocktail was then added to each experimental bag at a final concentration of 106 PFU/ml or 107
PFU/ml. The same amount of SM buffer was added to the control group in place of the
bacteriophage cocktail. All samples were then incubated at 20, 30, and 40°C for 6 h. Every hour,
raw material suspensions were removed and centrifuged (5,000 rpm) for 10 min and the
supernatant was poured off to separate bacteriophages from the sample. The pellets were then
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washed once in sterile saline and then suspended in sterile saline. Serial dilutions were spiralplated with an Autoplate 4000 (Spiral Biotech Norwood, MA) onto XLT-4/rif (100 µg/ml) for
Salmonella enumeration at 37° C for 24 h.
Bacteriophage treatment of Salmonella in finished rendered animal meals upon
rehydration: The bacteriophage cocktail and Salmonella were suspended in sterile 10% skim
milk and tryptic soy broth (TSB), respectively, and lyophilized using a Vir Tis Model 7.0 freeze
dryer (SP industries NY) for ca. 24 h. Irradiated (1.5 MRad at 6,133 R/min) blood, feather, and
poultry meals were divided into four treatment groups each. Group 1 had lyophilized Salmonella
cocktail added at a concentration of 105 CFU/g. Group 2 had both lyophilized bacteriophage and
Salmonella cocktails added at concentrations of 106 PFU/g or 107 PFU/g and 105 CFU/g,
respectively. Group 3 had lyophilized bacteriophage cocktail added at a concentration of 106
PFU/g or 107 PFU/g. Group 4 had no additives. The samples were kept in sterile whirl-pak bags
at 30°C for a period of 1 month.
For the rehydration study, samples from groups 1 and 2 were collected weekly and
suspended into buffered peptone water. Samples from group 3 and 4 were collected weekly and
suspended into buffered peptone water that was inoculated with the Salmonella cocktail at a
concentration of 105 CFU/ml. The samples were incubated at 30°C for 24 h with samples taken
at pre-determined time intervals. The samples were centrifuged and the supernatant was poured
off to remove bacteriophages from the sample. The pellets were washed as described for the raw
meat samples and then suspended in sterile saline. Serial dilutions were made with sterile saline
and spiral plated onto XLT-4. All plates were incubated at 37°C and enumerated after 24 h.
An additional trial was conducted as described above with lyophilized bacteriophage at a
concentration of 106 PFU/g. During this additional study, a second bacteriophage cocktail
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(suspended in SM buffer) was added to the experimental groups at a MOI of 10 at the 12h
sampling time.
Stability of lyophilized bacteriophages in dry meals: In addition to testing the lytic
effectiveness of the lyophilized bacteriophage, the stability of the bacteriophage cocktail in dry
meals was determined as well. The supernatant removed during Salmonella enumeration was
added to molten TSA along with the Salmonella cocktail (105 CFU/ml). The molten TSA was
overlayed onto TSA and incubated for 24 h at 37°C. Following incubation, plaque counts were
made to determine the amount of bacteriophage reduction over the course of the month-long
trial.
The stability of the liquid phage in the dry rodent feed was also determined at
refrigeration temperatures (4°C). The bacteriophage cocktail (1 ml) was added to dry, sterile
rodent feed at a concentration of 108 PFU/g. The feed was kept inside sterile-whirl pak bags at
4°C for 4 weeks. Samples were removed weekly and suspended in sterile saline. The
bacteriophage titer was determined as described above using the agar overlay method.
In vivo study with Balb/c mice: Female Balb/c mice (4-6 weeks, Harlan Laboratories)
were housed in sterile micro-isolater cages with sterile bedding at the Godley Snell Research
Center (Clemson, SC). The mice (n=10) were divided into two groups equally. All mice were
given water containing gentamicin (4 mg/l) to reduce background microbial population. The
experimental group were given a dough diet (Bio-Serv) supplemented with the bacteriophage
cocktail at a MOI of 100. The control mice were given the dough diet with no additives. After 7
days of acclimation, feed was removed for 24 h. Following this 24 h period, all mice were
anesthetized with 2.5% isofluorane mixed with 1.5% oxygen and orally administered 0.20 ml of
S. Enteritidis H4717 ( 106 CFU/mouse) using gavage needles. After oral challenge, the mice
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were returned to their respective diets for a period of 4 weeks. Both the weight and behavior of
each mouse was observed for the duration of the experiment. All procedures were approved by
Clemson University’s Institutional Animal Care and Use committee.
Analysis of Salmonella levels in fecal content during mouse trial: Twenty-four hours
after arrival of the mice, one gram of feces from each cage was collected aseptically and
homogenized in sterile saline using a stomacher 400 circulator (Seward) for 5 min. Samples were
enriched in Rappaport-Vassiliadis (RV) broth for 24 h followed by spread-plating onto XLT-4 to
ensure the mice were free of Salmonella.
Feces samples were collected and homogenized from each cage at 24 h post-infection as
described above. Homogenized samples were centrifuged at 5,000x rpm and the supernatant
removed. The pellet was washed and resuspended in sterile saline. Serial dilutions were made in
sterile saline and spiral-plated onto XLT-4/ rif. Salmonella levels were determined following 24
h incubation at 37°C. Fecal sampling was conducted in the same manner twice weekly during
the 4 week trial.
Analysis of Salmonella levels and histological analysis of intestinal and liver tissue
collected during the mouse trial: At the end of the 4-week trial, all mice were euthanized using
isofluorane. The liver and intestine were aseptically removed from 2 mice in each group.
Approximately 50% of each organ was collected and suspended in sterile saline for Salmonella
enumeration, and the remaining tissues were sent to the Clemson Veterinary Diagnostic Center
(Columbia, SC) for histological analysis.
For enumeration, each tissue sample was weighed out, and one gram samples were
homogenized in sterile saline using a glass tissue grinder. The homogenized samples were then
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used to make serial dilutions in sterile saline. The dilutions were spiral-plated onto XLT-4/rif and
incubated at 37°C for 24 h.
For histological analysis, the tissue samples were fixated in 10% formalin, cut, and
embedded in paraffin. Cross-sections were mounted on glass slides, air dried, and stained with
hematoxylin and eosin (H&E). Pathological analysis was then performed on all tissue samples by
one pathologist.
Statistical analysis. All Salmonella counts were converted into log values. The mean
counts and standard deviations were determined for the samples. The data were subjected to
analysis of variance with a test criterion (F statistic) and type I error controlled at P = 0.05. The
Tukey’s multiple comparison procedure of the Statistical Analysis System (SAS 2001, Cary,
NC) was used to compare all pairs of means when the test criterion for the analysis of variance
was significant.
Results
Salmonella enumeration from the raw chicken offal revealed a contamination level of ca.
105 CFU/g (data not shown). Treatment of the raw chicken offal was effective at both a MOI of
10 and 100, with no significant difference (P>0.05) in the effectiveness of the two (Fig. 4.1).
After 6 h of incubation the average differences between Salmonella levels in the bacteriophage
treated (MOI of 10 and 100) and non-treated groups were ca. 2.0, 2.7, and 2.5 log CFU/g in the
sterile chicken offal at 20°, 30°, and 40°C, respectively (Fig. 4.1a, b, c). The differences between
Salmonella levels in the bacteriophage treated (MOI of 10 and 100) and non-treated groups in
non-sterile offal were ca. 2.0, 2.2, and 2.2 log CFU/g at 20°, 30°, and 40°C, respectively (Fig.
4.1d, e, f). In the control group, Salmonella grew ca. 0.5 log CFU/g more in the sterile offal as
compared with the non-sterile offal.
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Experiments were designed to study the suppressive effect of lyophilized bacteriophage
on the growth of Salmonella during rehydration of the contaminated animal meals (blood,
feather, and poultry) (Table 4.1). Salmonella counts in the rendered meals decreased by ca. 1 log
CFU/g during the 4 week study (Fig. 4.2). During the rehydration step, the changes in
Salmonella counts within blood meal in the presence of lyophilized bacteriophage (MOI of 10
and 100) are presented in Table 4.1a. In the blood meal, there was ca. a 1.5, 1.5, 1.0, and 0.8 log
CFU/g difference between the control and treated (MOI of 10) samples at weeks 1-4,
respectively, as compared with ca. a 2.0, 1.5, 1.5, and 1.0 log CFU/g difference between the
control and treated samples when using a MOI of 100. The effect of the lyophilized
bacteriophage on Salmonella in both the feather and poultry meal resulted in similar differences
(Tables 4.1b-c).
To determine if the lyophilized bacteriophage can prevent the contamination of animal
meals during the rehydration step, fresh Salmonella was added to the meals containing the
bacteriophages (treatment group 3). The level of Salmonella reduction was similar to those
observed when the Salmonella was already present in the meal (Table 4.1). In both studies, there
was no significant difference (P>0.05) in Salmonella levels between the control and
bacteriophage-treated samples in all meals after 24 h (data not shown).
To determine if a fresh, liquid culture of bacteriophage could reduce Salmonella levels in
rehydrated animal meals, a different bacteriophage cocktail (MOI of 10) suspended in SM buffer
was added directly to the meals following 12 h of rehydration (treatment group 1). The
difference in Salmonella growth in the control and treated samples was in the range of 0.7-1.4
log CFU/g after the remaining 12 h of incubation. The fresh bacteriophage reduced the amount
of Salmonella by ca. 1 log CFU/g in all meal types (Table 4.2).
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Analysis of the stability of the lyophilized bacteriophage cocktail within the dry finished
meals at 30°C, revealed that the concentration decreased by ca. 1.5 log PFU/g over the 4-week
test period (Fig. 4.3). Stability testing of the fresh bacteriophage inoculated into the animal feed
used for the mice study at 4°C revealed that the bacteriophage concentration had ca. a 3%
decrease (0.23 log PFU/g) over the 4-week trial (Fig. 4.4).
To determine the feasibility of using bacteriophage as a feed additive for Salmonella
control, a small animal study was conducted. Our preliminary study suggested that Salmonella
infection in mice follows a dose dependent pattern. At inoculation levels of 5x108 Salmonella
CFU/mouse, all mice were killed by the end of a two week trial. By reducing the initial
inoculation level to 5x106 CFU/mouse, our animal study revealed that no Salmonella was
detected in the fecal samples from the experimental group throughout the 4-week trial; however,
Salmonella was detected in the fecal samples from the control group up to 2.5 weeks (Table 4.3).
The liver and intestinal tract of both the control and experimental mice were free of Salmonella
4-weeks post-infection as determined by the plate-counting method. The histological analysis
gave no indications of inflammation associated with Salmonella infection in the liver and
intestine of the experimental mice; however, it did reveal venous dilation in the liver of the
control mice. In the liver of one control sample, monocytes were found in the portal areas and
cholangiohepatitis was observed. The intestine for the control mice showed no signs of
inflammation.
Discussion
Salmonella is an important foodborne pathogen affecting the microbial safety of rendered
animal by-products. A study conducted by Watkins et al. (1959) detected Salmonella in 18.5% of
the finished rendered products tested; whereas in our previous study, Salmonella was detected in
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8.7% of the finished rendered samples tested (Kinley et al., 2009). The current study
demonstrated that the level of Salmonella present in finished product decrease at a rate of 1 log
CFU/g per month, suggesting the pathogen can persist for long periods of time within these
products. The presence of Salmonella in the finished products can result from either insufficient
heat processing or post-processing contamination. The previous study by Kinley et al. (2009)
suggests that contamination may arise from cross-contamination. The Salmonella isolates
collected during that study had a maximum D-value of 45 sec at 65°C, which is at least 50°C
lower than the 115-145°C temperatures used during the rendering process (Anderson, 2006).
A likely source for cross contamination is the incoming raw material, which may have
already been contaminated with pathogenic bacteria such as Salmonella. The current study has
indicated that the average Salmonella count from raw chicken offal is ca. 105 CFU/g. This level
is in agreement with the 5.8-6.3 log CFU/g of Salmonella on raw broiler carcasses reported by
Kotula and Pandya (1995). Troutt et al. (2001) reported that 84.5% of the raw products collected
from U.S. rendering facilities were contaminated by Salmonella.
Previous studies have revealed that treatment of raw meats is successful for Salmonella
reduction when using a bacteriophage cocktail. For example, Higgens (2005) demonstrated that a
72 phage cocktail was capable of reducing S. Enteritidis (SE) by as much as 60% on poultry
carcasses. Goode et al. (2003) reported that using a bacteriophage cocktail at a MOI of 100 or
1000 could decrease Salmonella by 2 log CFU/cm2 on chicken skin. Fiorentin et al. (2005)
demonstrated that SE levels in the rinse water of artificially contaminated chicken skin (106
CFU/cut) could be significantly reduced (P<0.05) with a bacteriophage cocktail at a MOI of
1000. In this study, the maximum observed reduction in Salmonella levels in raw chicken offal
by bacteriophage treatment was 2.7 log CFU/g at 30° and 40°C. The lack of a significant
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difference between the efficacy of the bacteriophage treatment at a MOI of 10 and 100 may
suggest the bacteriophage cocktail reaches maximum efficacy at a MOI of 10. There was also no
notable difference between the treatment of the irradiated offal and the offal that was not
sterilized, which indicates that a bacteriophage cocktail is host-specific and is less affected by
background microorganisms. This study has shown that bacteriophage treatment can serve as an
effective way to lower Salmonella contamination in the raw material, thereby reducing the
probability for cross-contamination in the rendering facility.
Aside from preventing Salmonella contamination in the finished product, the current
study aimed to determine the potential for bacteriophage to be used as a feed additive when the
finished product is already contaminated with Salmonella. To accomplish this, we tried to
determine if the bacteriophage cocktail could remain alive within the finished rendered product.
The results indicated that the bacteriophage levels decrease by 1.5 log PFU/g within 4 weeks.
This relatively short shelf life means that for lyophilized bacteriophage to be effective as a feed
additive, the feed would either need to be used shortly after being mixed together with
bacteriophage or that the bacteriophage would have to be added at a concentration far exceeding
the minimal lytic concentration. For example, in this study the bacteriophage cocktail was
initially added to the meals at a MOI of 10, but the bacteriophage titers had reduced quickly
during storage, resulting in a MOI of 1 within two weeks.
In this study, we also determined if bacteriophages within the feed could be reactivated
upon rehydration to reduce Salmonella levels. The results indicated that the lyophilized
bacteriophages, at a MOI of 10 and 100, was unsuccessful at eliminating the growth Salmonella
in the feed during rehydration; however, there was a significant (P<0.05) difference in
Salmonella levels between samples containing bacteriophage and those without. The
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bacteriophages did slow the rate of Salmonella growth (average 2 log reduction as compared
with the control) through 12 h of rehydration. These results suggest that Salmonella can be
controlled to some extent by bacteriophage treatment when the rendered meal becomes
rehydrated upon animal consumption. While there are no known studies using lyophilized
bacteriophages for pathogen control, Kim et al. (2007) added a bacteriophage cocktail to
reconstituted infant formula and reported that the bacteriophages were able to reduce
Enterobacter sakazakii (OD600=0.5) levels by 1 log CFU/g after at 24°C using the bacteriophage
cocktail at a MOI of 1 and 10 for 12 h. In this study, we were able to reduce Salmonella level by
ca. 1 log CFU/g after a 12 h period in the rehydrated meals using fresh bacteriophage. The
results suggest that the lyophilized bacteriophage may require a recovery period while fresh
bacteriophage is already active when it is added to the rehydrated meal.
There have been many studies indicating the potential of bacteriophages as therapeutic
agents. Initial bacteriophage therapeutic trials date back to the work of d’Herelle (1921). He was
able to use bacteriophage treatment to reduce the occurrence of avian typhosis in chicken flocks
across France. D’Herelle (1926) also demonstrated that water supplemented with bacteriophage
prevented Pasteurella multocida infection in water buffalo. More recently, Smith and Huggins
(1983) demonstrated that a bacteriophage cocktail could be used to reduce the mortality rate due
to E. coli O9:K30.99 infection from 100 to 17% in calves. Berchieri et al. (2001) showed that a
bacteriophage cocktail could be used to reduce S. Typhimurium levels in the intestine, crop, and
cecae by 1 log within 12 h of bacteriophage administration. The study by Berchieri et al (2001)
and the current study both demonstrate that bacteriophage therapy can be effective at reducing
Salmonella if given before the pathogenic cells can enter the epithelial cells. In our animal trial,
the experimental mice were given the bacteriophage supplemented feed a week prior to

152

inoculation. The results of fecal sampling indicated that the bacteriophages were able to prevent
Salmonella infection immediately after pathogen challenge. Fecal shedding of Salmonella in the
control mice indicated that Salmonella successfully infected the host; however, the tissue
analysis indicated that at the end of the 4-week trial, Salmonella was no longer detected in any of
the mice. Histological analysis did not detect any signs of inflammation due to Salmonella
infection in the experimental mice; whereas, the control mice had some signs of inflammation
associated with Salmonella infection in the liver which suggested the mice were initially
infected.
This study has demonstrated that a bacteriophage cocktail can be used to effectively
reduce Salmonella populations within the raw material used for rendering at temperatures
ranging from 20-40°C, which reduces the probability of cross-contamination. The presence of
background microorganisms does not significantly affect the efficacy of the bacteriophage
treatment. It was also shown that the stability of the bacteriophage as a feed additive is
maintained when the bacteriophage is added n liquid form and stored at refrigeration
temperatures. The study also suggests that the presence of lyophilized bacteriophages in
rehydrated meals does not eliminate Salmonella growth but slows the rate of Salmonella growth
during the rehydration step. By adding fresh bacteriophages to the rehydrated meals, Salmonella
populations were reduced by ca. 1 log CFU/g, suggesting that fresh bacteriophage has potential
as a feed additive. This was further supported by the animal study, where mice given feed
supplemented with fresh bacteriophage prior to inoculation showed no indications of Salmonella
infection. Overall results have demonstrated that fresh bacteriophage may be effective at
reducing Salmonella levels at the farm level when added close to the time of consumption;
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however, additional animal testing is needed to optimize bacteriophage treatment across various
species due to differences in the gastrointestinal systems between animals.
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Figure legends
Fig. 1. Bacteriophage treatment of Salmonella in sterile raw chicken offal at 20° (a), 30° (b), and
40°C (c), and non-sterile raw chicken offal at 20° (d), 30° (e), and 40°C (f). Symbols were
Control (♦), MOI of 10 (■), and MOI of 100 (▲).
Fig. 2. Stability of Salmonella in finished rendered meal over at 30°C.
Fig. 3. Stability of lyophilized bacteriophage with MOI of 10 and 100 infinished rendered meal.
Symbols were MOI of 10 (■) and MOI of 100 (♦).
Fig. 4. Stability of bacteriophage in animal feed stored at 4°C.

158

Figure 4.1

0

1

2

3
4
Time (h)

a)

5

6.5
6.0
5.5
5.0
4.5
4.0

6

d)

7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0

Salmonella (log CFU/g)

Salmonella (log CFU/g)

7.0

Salmonella (log CFU/g)

Salmonella (log CFU/g)

7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0

0

1

2

b)

3
4
Time (h)

5

0

1

2 Time
3 (h) 4

5

6

6.5
6.0
5.5
5.0
4.5
4.0

6

2

e)

3
4
Time (h)

5

6

7.0
Salmonella (log CFU/g)

Salmonella (log CFU/g)

1

7.0

7.5
7.0
6.5
6.0
5.5
5.0
4.5

6.5
6.0
5.5
5.0
4.5
4.0

4.0
0

c)

0

1

2

3
4
Time (h)

5

0

6

f)

159

1

2

3
4
Time (h)

5

6

Figure 4.2

Salmonella (log CFU/g)

5.5
5.0
4.5
4.0
3.5
0

1

2

3

4

3

4

Week
Figure 4.3

Bacteriophage log PFU/g

8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
0

1

2
Week

160

Figure 4.4
8.5
8.0
7.5
log PFU/g

7.0
6.5
6.0
5.5
5.0
4.5
4.0
0

1

2

3

Week

161

4

Table 4.1a. Changes in Salmonella populations in irradiated blood meal as affected by lyophilized bacteriophage
Lyophilized Salmonella
MOI 10

Fresh Salmonella

MOI 100

MOI 10

MOI 100

Storage Sampling
(Week)

time (h)

Control

Experimental

Control

Experimental

Control

Experimental

Control

Experimental

5.27±0.20*

5.12±0.10

6.00±0.20

5.24±0.21

0

4.95±0.23

5.04±0.23

4.86±0.38

4.96±0.14

4.97±0.11

5.10±0.10

5.12±0.04

4.87±0.25

12

8.62±0.18A**

7.05±0.17B

8.55±0.24A

6.40±0.16B

9.05±0.19A

7.48±0.28B

8.64±0.18A

6.81±0.13B

0

4.72±0.18

4.80±0.26

4.43±0.20

4.62±0.20

5.15±0.06

4.93±0.16

4.91±0.26

5.12±0.08

12

8.35±0.11A

6.71±0.07B

8.21±0.17A

6.63±0.07B

9.12±0.12A

7.55±0.13B

8.87±0.14A

6.93±0.19B

0

4.10±0.07

4.49±0.17

4.05±0.01

4.18±0.14

5.05±0.19

5.55±0.06

5.32±0.14

5.07±0.08

12

8.47±0.30A

7.31±0.16B

8.42±0.21A

7.02±0.14B

8.76±0.22A

7.61±0.11B

9.02±0.07A

8.22±0.11B

0

3.94±0.16

4.02±0.44

3.80±0.18

3.93±0.07

5.36±0.15

5.43±0.22

5.17±0.15

5.21±0.22

12

8.51±0.17A

7.66±0.38B

8.67±0.25A

7.28±0.35B

8.91±0.20A

8.14±0.15B

8.71±0.04A

8.03±0.09B

0
1

2

3

4

*Salmonella log CFU/g
**Letters represent different levels of significance between the control and experimental samples among test groups
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Table 4.1b. Changes in Salmonella populations in irradiated feather meal as affected by lyophlized bacteriophage
Lyophilized Salmonella
MOI 10

Fresh Salmonella

MOI 100

MOI 10

MOI 100

Storage Sampling
(Week)

time (h)

Control

Experimental

Control

Experimental

Control

Experimental

Control

Experimental

5.07±0.20*

4.98±0.21

4.91±0.18

5.16±0.17

0

5.32±0.21

4.93±0.23

4.73±0.06

4.88±0.27

5.39±0.16

4.73±0.26

5.06±0.23

4.80±0.20

12

8.44±0.24A**

6.62±0.13B

8.31±0.17A

6.27±0.11B

8.87±0.05A

7.11±0.16B

8.91±0.14A

7.04±0.14B

0

4.98±0.17

4.80±0.11

4.51±0.30

4.66±0.07

4.88±0.24

5.49±0.19

5.31±0.18

4.97±0.15

12

8.71±0.23A

6.88±0.17B

8.20±0.20A

6.12±0.24B

9.14±0.16A

7.37±0.07B

8.73±0.20A

6.90±0.09B

0

4.76±0.16

4.51±0.11

4.17±0.20

4.29±0.30

4.94±0.10

4.96±0.21

4.88±0.16

5.18±0.17

12

8.55±0.23A

7.22±0.04B

8.27±0.30A

6.89±0.03B

9.03±0.03A

7.19±0.14B

8.80±0.15A

7.96±0.06B

0

4.37±0.35

4.10±0.10

3.97±0.21

4.04±0.08

5.04±0.11

5.35±0.28

5.11±0.33

5.22±0.27

12

8.31±0.17A

7.66±0.18B

7.96±0.11A

6.55±0.11B

8.76±0.19A

8.14±0.16B

9.11±0.08A

8.41±0.13B

0
1

2

3

4

*Salmonella log CFU/g
**Letters represent different levels of significance between the control and experimental samples among test groups
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Table 4.1c. Changes in Salmonella populations in irradiated poultry meal as affected by lyophilized bacteriophage
Lyophilized Salmonella
MOI 10

Fresh Salmonella

MOI 100

MOI 10

MOI 100

Storage Sampling
(Week)

time (h)

Control

Experimental

Control

Experimental

Control

Experimental

Control

Experimental

5.17±0.14*

5.08±0.14

5.32±0.21

5.01±0.11

0

5.32±0.18

4.98±0.17

5.04±0.10

4.81±0.06

4.98±0.10

5.66±0.17

5.20±0.18

5.02±0.28

12

7.92±0.20A**

6.44±0.07B

8.47±0.11A

6.52±0.18B

9.10±0.06A

7.63±0.07B

8.78±0.19A

6.92±0.08B

0

4.93±0.11

4.89±0.18

4.70±0.11

4.57±0.18

5.59±0.23

4.89±0.13

5.11±0.04

5.37±0.16

12

7.77±0.25A

6.09±0.10B

8.31±0.27A

6.08±0.04B

8.94±0.18A

7.21±0.22B

8.93±0.12A

7.10±0.12B

0

4.80±0.18

4.72±0.04

4.33±0.16

4.30±0.33

5.61±0.19

4.76±0.29

4.92±0.24

5.13±0.09

12

7.94±0.17A

6.87±0.17B

8.30±0.38A

7.06±0.21B

8.87±0.11A

7.78±0.06B

8.64±0.08A

7.74±0.19B

0

4.61±0.07

4.51±0.08

4.06±0.20

4.11±0.08

4.93±0.27

5.41±0.17

5.07±0.10

4.85±0.25

12

7.66±0.04A

6.93±0.08B

8.19±0.24A

6.72±0.25B

9.03±0.08A

8.17±0.14B

9.09±0.11A

8.26±0.16B

0
1

2

3

4

*Salmonella log CFU/g
**Letters represent different levels of significance between the control and experimental samples among test groups
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Table 4.2a. Changes in Salmonella populations in irradiated blood meal as affected by fresh bacteriophage
Storage

Sampling

(Week)

time (h)

Control

Experimental

5.18±0.08

5.02±0.20

12

8.42±0.18

7.07±0.08

24

9.26±0.24A*

6.13±0.11B

12

8.29±0.04

7.14±0.11

24

9.07±0.10A

6.22±0.23B

12

8.41±0.14

7.39±0.21

24

9.19±0.23A

6.26±0.07B

12

8.38±0.08

7.62±0.06

24

8.95±0.10A

6.46±0.10B

0
1

2

3

4

Salmonella (log CFU/g)

**Letters represent different levels of significance between the control and experimental samples
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Table 4.2b. Changes in Salmonella populations in irradiated feather meal as affected by fresh bacteriophage
Storage

Sampling

(week)

time (h)

Control

Experimental

5.17±0.17

5.08±0.13

12

8.28±0.07

6.96±0.11

24

9.01±0.16A*

5.97±0.13B

12

8.50±0.17

7.24±0.13

24

9.19±0.07A

6.04±0.11B

12

8.39±0.07

7.28±0.13

24

9.09±0.08A

6.22±0.24B

12

8.17±0.13

7.41±0.20

24

8.86±0.10A

6.35±0.06B

0
1

2

3

4

Salmonella (log CFU/g)

**Letters represent different levels of significance between the control and experimental samples
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Table 4.2c. Changes in Salmonella populations in irradiated poultry meal as affected by fresh bacteriophage
Storage

Sampling

Salmonella (log CFU/g)

(Week)

time (h)

Control

Experimental

4.97±0.10

5.06±0.11

12

8.22±0.10

6.84±0.11

24

9.10±0.11A*

5.86±0.14B

12

8.36±0.04

7.09±0.17

24

9.27±0.04A

6.17±0.16B

12

8.16±0.11

7.17±0.07

24

8.99±0.11A

6.24±0.13B

12

8.29±0.17

7.33±0.08

24

9.15±0.03A

6.41±0.20B

0
1

2

3

4

**Letters represent different levels of significance between the control and experimental samples
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Table 4.3. Salmonella enumeration in feces from mice
Treated

Untreated

Day

Group 1

Group 2

Group 3

Group 4

Group 5

1

BDL*

BDL

BDL

3.86±0.13**

4.79±0.13

4

BDL

BDL

BDL

3.78±0.25

4.08±0.20

8

BDL

BDL

BDL

2.85±0.11

2.78±0.04

11

BDL

BDL

BDL

3.45±0.27

3.20±0.08

15

BDL

BDL

BDL

2.60±0.06

3.00±0.13

18

BDL

BDL

BDL

BDL

BDL

22

BDL

BDL

BDL

BDL

BDL

25

BDL

BDL

BDL

BDL

BDL

* Below the detection limit 102 CFU/g
**Salmonella log CFU/g
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CONCLUSION
In this study we have demonstrated that finished rendered animal meals are often
contaminated with pathogenic bacteria such as Salmonella. Through thermal tolerance
testing we were able to determine the most likely cause of such contamination is post
processing contamination rather than inefficient heat processing. We were able to isolate
and optimize a bacteriophage cocktail that was capable of reducing Salmonella found on
surfaces (stainless steel, rubber, HDPE plastic, and concrete) common to a rendering
facility’s environment as well as in the incoming raw material. On average, up to 99.9%
of Salmonella populations were eliminated by bacteriophage treatment. By doing this, the
use of a bacteriophage cocktail could potentially reduce the probability of crosscontamination, leading to no contamination in the finished meals. In addition, our results
have demonstrated that a bacteriophage has the potential to be used as a feed additive.
Although the stability of the lyophilized bacteriophage’s in finished meals was decreased
when stored at 30°C, it was improved when fresh bacteriophage was added to the feed
and stored at 4°C. In addition to decreased stability, the lyophilized bacteriophage did not
prevent Salmonella growth but did slow Salmonella’s growth within the animal meals
through 12 h. The addition of fresh bacteriophage resulted in ca. a 1 log CFU/g reduction
in Salmonella populations within finished meal, suggesting the bacteriophage’s potential
as a feed additive is increased when using a fresh bacteriophage suspension. The
effectiveness of bacteriophage as a feed additive was further confirmed during an animal
trial. Mice receiving bacteriophage in their feed showed no signs of infection following
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Salmonella inoculation. In conclusion, we have demonstrated that a bacteriophage
cocktail can be used to reduce the risk of Salmonella contamination in the processing
environment, the feed, and upon feed consumption.
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